{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:16:49Z","timestamp":1794737809218,"version":"4.9.1"},"reference-count":361,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374552"],"award-info":[{"award-number":["82374552"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02631-6","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:01:56Z","timestamp":1780441316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuqing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-0942","authenticated-orcid":false,"given":"Weijun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0428-3928","authenticated-orcid":false,"given":"Zhaoqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"2631_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","volume":"629","author":"EV Minikel","year":"2024","unstructured":"Minikel, E. V., Painter, J. L., Dong, C. C. & Nelson, M. R. Refining the impact of genetic evidence on clinical success. Nature 629, 624\u2013629 (2024).","journal-title":"Nature"},{"key":"2631_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gutjnl-2023-331740","volume":"74","author":"S Ghosh","year":"2025","unstructured":"Ghosh, S. et al. Artificial intelligence applied to \u2018omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment. Gut 74, 295\u2013311 (2025).","journal-title":"Gut"},{"key":"2631_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He, X. et al. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin. Cancer Biol. 88, 187\u2013200 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"2631_CR4","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1109\/TPAMI.2022.3209686","volume":"45","author":"A Bessadok","year":"2023","unstructured":"Bessadok, A., Mahjoub, M. A. & Rekik, I. Graph neural networks in network neuroscience. IEEE Trans. Pattern Anal. Mach. Intell. 45, 5833\u20135848 (2023).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"key":"2631_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-022-00938-y","volume":"44","author":"XH He","year":"2023","unstructured":"He, X. H. et al. AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors. Acta Pharmacol. Sin. 44, 1\u20137 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"2631_CR6","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/pcm.2024.4","volume":"2","author":"A Wenteler","year":"2024","unstructured":"Wenteler, A. et al. AI approaches for the discovery and validation of drug targets. Camb. Prism. Precis. Med. 2, e7 (2024).","journal-title":"Camb. Prism. Precis. Med."},{"key":"2631_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s43587-024-00692-2","volume":"4","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat. Aging 4, 1619\u20131634 (2024).","journal-title":"Nat. Aging"},{"key":"2631_CR8","doi-asserted-by":"publisher","first-page":"1514977","DOI":"10.3389\/fimmu.2024.1514977","volume":"15","author":"L Hai","year":"2024","unstructured":"Hai, L., Jiang, Z., Zhang, H. & Sun, Y. From multi-omics to predictive biomarker: AI in tumor microenvironment. Front. Immunol. 15, 1514977 (2024).","journal-title":"Front. Immunol."},{"key":"2631_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.csbj.2024.12.030","volume":"27","author":"Y Wu","year":"2025","unstructured":"Wu, Y. & Xie, L. AI-driven multi-omics integration for multi-scale predictive modeling of genotype-environment-phenotype relationships. Comput. Struct. Biotechnol. J. 27, 265\u2013277 (2025).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2631_CR10","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41592-024-02201-0","volume":"21","author":"H Cui","year":"2024","unstructured":"Cui, H. et al. scGPT: toward building a foundation model for single-cell multi-omics using generative AI. Nat. Methods 21, 1470\u20131480 (2024).","journal-title":"Nat. Methods"},{"key":"2631_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcancer.2023.02.009","volume":"91","author":"J Li","year":"2023","unstructured":"Li, J. et al. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer. Semin. Cancer Biol. 91, 35\u201349 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"2631_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.exphem.2018.09.008","volume":"68","author":"V Giudice","year":"2018","unstructured":"Giudice, V. et al. Aptamer-based proteomics of serum and plasma in acquired aplastic anemia. Exp. Hematol. 68, 38\u201350 (2018).","journal-title":"Exp. Hematol."},{"key":"2631_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10875-024-01793-8","volume":"45","author":"F Saettini","year":"2024","unstructured":"Saettini, F. et al. Biallelic PI4KA mutations disrupt B-cell metabolism and cause B-cell lymphopenia and hypogammaglobulinemia. J. Clin. Immunol. 45, 15 (2024).","journal-title":"J. Clin. Immunol."},{"key":"2631_CR14","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.arr.2022.101730","volume":"81","author":"W Li","year":"2022","unstructured":"Li, W. et al. Multi-omics research strategies in ischemic stroke: a multidimensional perspective. Ageing Res. Rev. 81, 101730 (2022).","journal-title":"Ageing Res. Rev."},{"key":"2631_CR15","doi-asserted-by":"crossref","unstructured":"Yang, H. et al. From multi-omics data to the cancer druggable gene discovery: a novel machine learning-based approach. Brief. Bioinform. 24, bbac528 (2023).","DOI":"10.1093\/bib\/bbac528"},{"key":"2631_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00442-z","volume":"18","author":"W Jiang","year":"2025","unstructured":"Jiang, W., Ye, W., Tan, X. & Bao, Y. J. Network-based multi-omics integrative analysis methods in drug discovery: a systematic review. BioData Min. 18, 27 (2025).","journal-title":"BioData Min."},{"key":"2631_CR17","doi-asserted-by":"publisher","first-page":"590742","DOI":"10.3389\/fimmu.2021.590742","volume":"12","author":"JM Zielinski","year":"2021","unstructured":"Zielinski, J. M., Luke, J. J., Guglietta, S. & Krieg, C. High Throughput multi-omics approaches for clinical trial evaluation and drug discovery. Front. Immunol. 12, 590742 (2021).","journal-title":"Front. Immunol."},{"key":"2631_CR18","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1038\/s41588-024-01999-x","volume":"56","author":"AM Lepp\u00e4","year":"2024","unstructured":"Lepp\u00e4, A. M. et al. Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype. Nat. Genet. 56, 2790\u20132803 (2024).","journal-title":"Nat. Genet."},{"key":"2631_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41328-0","volume":"14","author":"M Nishide","year":"2023","unstructured":"Nishide, M. et al. Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis. Nat. Commun. 14, 5789 (2023).","journal-title":"Nat. Commun."},{"key":"2631_CR20","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/all.16526","volume":"80","author":"N Baalbaki","year":"2025","unstructured":"Baalbaki, N. et al. The omics landscape of long COVID\u2014a comprehensive systematic review to advance biomarker, target and drug discovery. Allergy 80, 932\u2013948 (2025).","journal-title":"Allergy"},{"key":"2631_CR21","doi-asserted-by":"crossref","unstructured":"Rasooly, D., Pereira, A. C. & Joseph, J. Drug discovery and development for heart failure using multi-omics approaches. Int. J. Mol. Sci. 26, 2703 (2025).","DOI":"10.3390\/ijms26062703"},{"key":"2631_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2023.12.016","volume":"42","author":"C Pacini","year":"2024","unstructured":"Pacini, C. et al. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization. Cancer Cell 42, 301\u2013316.e309 (2024).","journal-title":"Cancer Cell"},{"key":"2631_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/0118746098348122241024061610","volume":"18","author":"A Bayat","year":"2024","unstructured":"Bayat, A. et al. New insights into colorectal cancer through the lens of precision oncology and personalized medicine: multi-omics helps aging of predisposed people. Curr. Aging Sci. 18, 193\u2013210 (2024).","journal-title":"Curr. Aging Sci."},{"key":"2631_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.315","volume":"4","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. Applications of multi-omics analysis in human diseases. MedComm 4, e315 (2023).","journal-title":"MedComm"},{"key":"2631_CR25","doi-asserted-by":"publisher","first-page":"1419363","DOI":"10.3389\/fimmu.2024.1419363","volume":"15","author":"Y Bai","year":"2024","unstructured":"Bai, Y. et al. Identification of drug targets for Sj\u00f6gren\u2019s syndrome: multi-omics Mendelian randomization and colocalization analyses. Front. Immunol. 15, 1419363 (2024).","journal-title":"Front. Immunol."},{"key":"2631_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ccell.2024.03.003","volume":"42","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemia. Cancer Cell 42, 552\u2013567.e556 (2024).","journal-title":"Cancer Cell"},{"key":"2631_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01356-x","volume":"16","author":"S Si","year":"2024","unstructured":"Si, S., Liu, H., Xu, L. & Zhan, S. Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. Genome Med. 16, 84 (2024).","journal-title":"Genome Med."},{"key":"2631_CR28","volume":"15","author":"R Mondal","year":"2023","unstructured":"Mondal, R. et al. Applications of clustered regularly interspaced short palindromic repeats (CRISPR) as a genetic scalpel for the treatment of cancer: a translational narrative review. Cureus 15, e50031 (2023).","journal-title":"Cureus"},{"key":"2631_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41582-020-0373-z","volume":"16","author":"M Kampmann","year":"2020","unstructured":"Kampmann, M. CRISPR-based functional genomics for neurological disease. Nat. Rev. Neurol. 16, 465\u2013480 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"2631_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.celrep.2019.03.047","volume":"27","author":"G MacLeod","year":"2019","unstructured":"MacLeod, G. et al. Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells. Cell Rep. 27, 971\u2013986.e979 (2019).","journal-title":"Cell Rep."},{"key":"2631_CR31","doi-asserted-by":"publisher","first-page":"2200014","DOI":"10.1002\/ggn2.202200014","volume":"3","author":"B McLean","year":"2022","unstructured":"McLean, B. et al. A CRISPR path to finding vulnerabilities and solving drug resistance: targeting the diverse cancer landscape and its ecosystem. Adv. Genet. 3, 2200014 (2022).","journal-title":"Adv. Genet."},{"key":"2631_CR32","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.21037\/tcr-23-1146","volume":"13","author":"Y Jin","year":"2024","unstructured":"Jin, Y. et al. Application and progress of CRISPR\/Cas9 gene editing in B-cell lymphoma: a narrative review. Transl. Cancer Res. 13, 1584\u20131595 (2024).","journal-title":"Transl. Cancer Res."},{"key":"2631_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41568-022-00441-w","volume":"22","author":"A Katti","year":"2022","unstructured":"Katti, A. et al. CRISPR in cancer biology and therapy. Nat. Rev. Cancer 22, 259\u2013279 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"2631_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-022-05504-4","volume":"612","author":"Z Xu","year":"2022","unstructured":"Xu, Z. et al. Structural variants drive context-dependent oncogene activation in cancer. Nature 612, 564\u2013572 (2022).","journal-title":"Nature"},{"key":"2631_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41592-018-0070-7","volume":"15","author":"S Bian","year":"2018","unstructured":"Bian, S. et al. Genetically engineered cerebral organoids model brain tumor formation. Nat. Methods 15, 631\u2013639 (2018).","journal-title":"Nat. Methods"},{"key":"2631_CR36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.trecan.2020.05.002","volume":"6","author":"S Li","year":"2020","unstructured":"Li, S., Zhang, Z. & Han, L. 3D spheroids propel tumor characterization. Trends Cancer 6, 622\u2013624 (2020).","journal-title":"Trends Cancer"},{"key":"2631_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1158\/2159-8290.CD-24-0101","volume":"14","author":"RJA Goodwin","year":"2024","unstructured":"Goodwin, R. J. A., Platz, S. J., Reis-Filho, J. S. & Barry, S. T. Accelerating drug development using spatial multi-omics. Cancer Discov. 14, 620\u2013624 (2024).","journal-title":"Cancer Discov."},{"key":"2631_CR38","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jacc.2023.09.801","volume":"82","author":"WHW Tang","year":"2023","unstructured":"Tang, W. H. W. & Koenig, W. Multiomics insights to accelerate drug development: will they hold their promises? J. Am. Coll. Cardiol. 82, 1932\u20131935 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2631_CR39","doi-asserted-by":"crossref","unstructured":"Wang, F. & Barrero, C. A. Multi-omics analysis identified drug repurposing targets for chronic obstructive pulmonary disease. Int. J. Mol. Sci. 25, 11106 (2024).","DOI":"10.3390\/ijms252011106"},{"key":"2631_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41586-021-04065-2","volume":"599","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Diverse alterations associated with resistance to KRAS(G12C) inhibition. Nature 599, 679\u2013683 (2021).","journal-title":"Nature"},{"key":"2631_CR41","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.jtho.2019.06.023","volume":"14","author":"T Fujino","year":"2019","unstructured":"Fujino, T. et al. Sensitivity and resistance of MET exon 14 mutations in lung cancer to eight MET tyrosine kinase inhibitors in vitro. J. Thorac. Oncol. 14, 1753\u20131765 (2019).","journal-title":"J. Thorac. Oncol."},{"key":"2631_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07922-3","volume":"10","author":"SA Baechler","year":"2019","unstructured":"Baechler, S. A. et al. The mitochondrial type IB topoisomerase drives mitochondrial translation and carcinogenesis. Nat. Commun. 10, 83 (2019).","journal-title":"Nat. Commun."},{"key":"2631_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01657-z","volume":"22","author":"H Zhao","year":"2024","unstructured":"Zhao, H. et al. APC\/C-regulated CPT1C promotes tumor progression by upregulating the energy supply and accelerating the G1\/S transition. Cell Commun. Signal 22, 283 (2024).","journal-title":"Cell Commun. Signal"},{"key":"2631_CR44","doi-asserted-by":"publisher","first-page":"188595","DOI":"10.1016\/j.bbcan.2021.188595","volume":"1876","author":"A Servetto","year":"2021","unstructured":"Servetto, A., Formisano, L. & Arteaga, C. L. FGFR signaling and endocrine resistance in breast cancer: challenges for the clinical development of FGFR inhibitors. Biochim Biophys. Acta Rev. Cancer 1876, 188595 (2021).","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"2631_CR45","doi-asserted-by":"crossref","unstructured":"Du, P. et al. Advances in integrated multi-omics analysis for drug-target identification. Biomolecules. 14, 692 (2024).","DOI":"10.3390\/biom14060692"},{"key":"2631_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43991-9","volume":"14","author":"Q Zhu","year":"2023","unstructured":"Zhu, Q. et al. Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines. Nat. Commun. 14, 8170 (2023).","journal-title":"Nat. Commun."},{"key":"2631_CR47","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.cmet.2024.03.006","volume":"36","author":"W Liang","year":"2024","unstructured":"Liang, W. et al. An integrated multi-omics analysis reveals osteokines involved in global regulation. Cell Metab. 36, 1144\u20131163.e1147 (2024).","journal-title":"Cell Metab."},{"key":"2631_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51767-y","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Unraveling the spatial organization and development of human thymocytes through integration of spatial transcriptomics and single-cell multi-omics profiling. Nat. Commun. 15, 7784 (2024).","journal-title":"Nat. Commun."},{"key":"2631_CR49","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","volume":"24","author":"K Vandereyken","year":"2023","unstructured":"Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24, 494\u2013515 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"2631_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41580-023-00615-w","volume":"24","author":"A Baysoy","year":"2023","unstructured":"Baysoy, A., Bai, Z., Satija, R. & Fan, R. The technological landscape and applications of single-cell multi-omics. Nat. Rev. Mol. Cell Biol. 24, 695\u2013713 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2631_CR51","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/s41586-025-08838-x","volume":"641","author":"Y Takei","year":"2025","unstructured":"Takei, Y. et al. Spatial multi-omics reveals cell-type-specific nuclear compartments. Nature 641, 1037\u20131047 (2025).","journal-title":"Nature"},{"key":"2631_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-024-01596-9","volume":"17","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications. J. Hematol. Oncol. 17, 72 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"2631_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat. Commun. 14, 2692 (2023).","journal-title":"Nat. Commun."},{"key":"2631_CR54","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell 43, 905\u2013924.e906 (2025).","journal-title":"Cancer Cell"},{"key":"2631_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","volume":"29","author":"WC Hsieh","year":"2022","unstructured":"Hsieh, W. C. et al. Spatial multi-omics analyses of the tumor immune microenvironment. J. Biomed. Sci. 29, 96 (2022).","journal-title":"J. Biomed. Sci."},{"key":"2631_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Y Qin","year":"2023","unstructured":"Qin, Y. et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol. Cancer 22, 59 (2023).","journal-title":"Mol. Cancer"},{"key":"2631_CR57","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","volume":"182","author":"RAT Mars","year":"2020","unstructured":"Mars, R. A. T. et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome. Cell 182, 1460\u20131473.e1417 (2020).","journal-title":"Cell"},{"key":"2631_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2508426","volume":"17","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases. Gut Microbes 17, 2508426 (2025).","journal-title":"Gut Microbes"},{"key":"2631_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03880-9","volume":"12","author":"F Zou","year":"2021","unstructured":"Zou, F. et al. Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis. 12, 582 (2021).","journal-title":"Cell Death Dis."},{"key":"2631_CR60","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1158\/2159-8290.CD-14-0501","volume":"4","author":"DR Donohoe","year":"2014","unstructured":"Donohoe, D. R. et al. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov. 4, 1387\u20131397 (2014).","journal-title":"Cancer Discov."},{"key":"2631_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13603-6","volume":"11","author":"HN Sanchez","year":"2020","unstructured":"Sanchez, H. N. et al. B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nat. Commun. 11, 60 (2020).","journal-title":"Nat. Commun."},{"key":"2631_CR62","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.ymthe.2023.03.024","volume":"31","author":"L Bendixen","year":"2023","unstructured":"Bendixen, L., Jensen, T. I. & Bak, R. O. CRISPR-Cas-mediated transcriptional modulation: the therapeutic promises of CRISPRa and CRISPRi. Mol. Ther. 31, 1920\u20131937 (2023).","journal-title":"Mol. Ther."},{"key":"2631_CR63","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41596-021-00639-6","volume":"17","author":"V de Bakker","year":"2022","unstructured":"de Bakker, V., Liu, X., Bravo, A. M. & Veening, J. W. CRISPRi-seq for genome-wide fitness quantification in bacteria. Nat. Protoc. 17, 252\u2013281 (2022).","journal-title":"Nat. Protoc."},{"key":"2631_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-023-06570-y","volume":"622","author":"AJ Santinha","year":"2023","unstructured":"Santinha, A. J. et al. Transcriptional linkage analysis with in vivo AAV-Perturb-seq. Nature 622, 367\u2013375 (2023).","journal-title":"Nature"},{"key":"2631_CR65","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.cell.2022.05.013","volume":"185","author":"JM Replogle","year":"2022","unstructured":"Replogle, J. M. et al. Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq. Cell 185, 2559\u20132575.e2528 (2022).","journal-title":"Cell"},{"key":"2631_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44175-1","volume":"15","author":"J Hou","year":"2024","unstructured":"Hou, J. et al. Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection. Nat. Commun. 15, 109 (2024).","journal-title":"Nat. Commun."},{"key":"2631_CR67","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41380-024-02841-w","volume":"30","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction. Mol. Psychiatry 30, 2362\u20132371 (2025).","journal-title":"Mol. Psychiatry"},{"key":"2631_CR68","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41586-024-08030-7","volume":"635","author":"MG Heffel","year":"2024","unstructured":"Heffel, M. G. et al. Temporally distinct 3D multi-omic dynamics in the developing human brain. Nature 635, 481\u2013489 (2024).","journal-title":"Nature"},{"key":"2631_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2020.03.008","volume":"89","author":"J Richetto","year":"2021","unstructured":"Richetto, J. & Meyer, U. Epigenetic modifications in schizophrenia and related disorders: molecular scars of environmental exposures and source of phenotypic variability. Biol. Psychiatry 89, 215\u2013226 (2021).","journal-title":"Biol. Psychiatry"},{"key":"2631_CR70","first-page":"24","volume":"10","author":"LK Guo","year":"2023","unstructured":"Guo, L. K. et al. Prediction of treatment response to antipsychotic drugs for precision medicine approach to schizophrenia: randomized trials and multiomics analysis. Mil. Med. Res. 10, 24 (2023).","journal-title":"Mil. Med. Res."},{"key":"2631_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-94303-8","volume":"15","author":"W Yang","year":"2025","unstructured":"Yang, W., Liu, C., Li, Z. & Cui, M. Multi-omic biomarkers associated with multiple sclerosis: from Mendelian randomization to drug prediction. Sci. Rep. 15, 9421 (2025).","journal-title":"Sci. Rep."},{"key":"2631_CR72","doi-asserted-by":"publisher","first-page":"1418560","DOI":"10.3389\/fphar.2024.1418560","volume":"15","author":"QJ Han","year":"2024","unstructured":"Han, Q. J. et al. PTGES2 and RNASET2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and MR-PheWAS analyses. Front. Pharmacol. 15, 1418560 (2024).","journal-title":"Front. Pharmacol."},{"key":"2631_CR73","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1007\/s10067-024-07136-7","volume":"43","author":"J Xie","year":"2024","unstructured":"Xie, J. et al. Identification of genetic association between mitochondrial dysfunction and knee osteoarthritis through integrating multi-omics: a summary data-based Mendelian randomization study. Clin. Rheumatol. 43, 3487\u20133496 (2024).","journal-title":"Clin. Rheumatol."},{"key":"2631_CR74","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12933-024-02431-8","volume":"23","author":"K Shi","year":"2024","unstructured":"Shi, K. et al. Identification of potential therapeutic targets for nonischemic cardiomyopathy in European ancestry: an integrated multiomics analysis. Cardiovasc. Diabetol. 23, 338 (2024).","journal-title":"Cardiovasc. Diabetol."},{"key":"2631_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-3-030-91836-1_7","volume":"1361","author":"RV Rapicavoli","year":"2022","unstructured":"Rapicavoli, R. V., Alaimo, S., Ferro, A. & Pulvirenti, A. Computational methods for drug repurposing. Adv. Exp. Med. Biol. 1361, 119\u2013141 (2022).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2631_CR76","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.esmoop.2023.101642","volume":"8","author":"M Aldea","year":"2023","unstructured":"Aldea, M. et al. Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision? ESMO Open 8, 101642 (2023).","journal-title":"ESMO Open"},{"key":"2631_CR77","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3389\/fphar.2019.01653","volume":"10","author":"SY Lee","year":"2019","unstructured":"Lee, S. Y. et al. A proteotranscriptomic-based computational drug-repositioning method for Alzheimer\u2019s disease. Front. Pharmacol. 10, 1653 (2019).","journal-title":"Front. Pharmacol."},{"key":"2631_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111717","volume":"41","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer\u2019s disease. Cell Rep. 41, 111717 (2022).","journal-title":"Cell Rep."},{"key":"2631_CR79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2022.07.008","volume":"29","author":"AM Albuquerque","year":"2023","unstructured":"Albuquerque, A. M. et al. Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. Clin. Microbiol Infect. 29, 13\u201321 (2023).","journal-title":"Clin. Microbiol Infect."},{"key":"2631_CR80","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cmi.2022.10.015","volume":"29","author":"T Karampitsakos","year":"2023","unstructured":"Karampitsakos, T. et al. Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial. Clin. Microbiol. Infect. 29, 372\u2013378 (2023).","journal-title":"Clin. Microbiol. Infect."},{"key":"2631_CR81","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-021-00898-1","volume":"22","author":"H Guo","year":"2021","unstructured":"Guo, H. et al. Multi-omics analyses reveal that HIV-1 alters CD4(+) T cell immunometabolism to fuel virus replication. Nat. Immunol. 22, 423\u2013433 (2021).","journal-title":"Nat. Immunol."},{"key":"2631_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108693","volume":"178","author":"S Zhou","year":"2024","unstructured":"Zhou, S. et al. Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification. Comput. Biol. Med. 178, 108693 (2024).","journal-title":"Comput. Biol. Med."},{"key":"2631_CR83","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3389\/fphar.2018.00583","volume":"9","author":"TM Nguyen","year":"2018","unstructured":"Nguyen, T. M. et al. DeCoST: a new approach in drug repurposing from control system theory. Front. Pharmacol. 9, 583 (2018).","journal-title":"Front. Pharmacol."},{"key":"2631_CR84","first-page":"323","volume":"21","author":"X Li","year":"2023","unstructured":"Li, X. et al. Network pharmacology approaches for research of traditional Chinese medicines. Chin. J. Nat. Med. 21, 323\u2013332 (2023).","journal-title":"Chin. J. Nat. Med."},{"key":"2631_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155834","volume":"132","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota. Phytomedicine 132, 155834 (2024).","journal-title":"Phytomedicine"},{"key":"2631_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.116092","volume":"305","author":"J Ye","year":"2023","unstructured":"Ye, J. et al. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke. J. Ethnopharmacol. 305, 116092 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"2631_CR87","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-0716-3291-8_4","volume":"2684","author":"M Mokou","year":"2023","unstructured":"Mokou, M. et al. A drug repurposing pipeline based on bladder cancer integrated proteotranscriptomics signatures. Methods Mol. Biol. 2684, 59\u201399 (2023).","journal-title":"Methods Mol. Biol."},{"key":"2631_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215717","volume":"540","author":"S Timilsina","year":"2022","unstructured":"Timilsina, S. et al. The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events. Cancer Lett. 540, 215717 (2022).","journal-title":"Cancer Lett."},{"key":"2631_CR89","doi-asserted-by":"publisher","first-page":"e17044","DOI":"10.7554\/eLife.17044","volume":"6","author":"I Kandela","year":"2017","unstructured":"Kandela, I. & Aird, F. Replication study: discovery and preclinical validation of drug indications using compendia of public gene expression data. eLife 6, e17044 (2017).","journal-title":"eLife"},{"key":"2631_CR90","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/s41591-024-03224-y","volume":"30","author":"S Lee","year":"2024","unstructured":"Lee, S. et al. High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activity. Nat. Med. 30, 3196\u20133208 (2024).","journal-title":"Nat. Med."},{"key":"2631_CR91","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.expneurol.2017.09.006","volume":"299","author":"A Daher","year":"2018","unstructured":"Daher, A. & de Groot, J. Rapid identification and validation of novel targeted approaches for glioblastoma: a combined ex vivo-in vivo pharmaco-omic model. Exp. Neurol. 299, 281\u2013288 (2018).","journal-title":"Exp. Neurol."},{"key":"2631_CR92","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","volume":"3","author":"JT Dudley","year":"2011","unstructured":"Dudley, J. T. et al. Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci. Transl. Med. 3, 96ra76 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2631_CR93","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40618-022-01923-2","volume":"46","author":"B Aydin","year":"2023","unstructured":"Aydin, B. et al. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors. J. Endocrinol. Invest. 46, 727\u2013747 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"2631_CR94","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-023-02779-x","volume":"42","author":"D Boso","year":"2023","unstructured":"Boso, D. et al. Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts. J. Exp. Clin. Cancer Res. 42, 196 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2631_CR95","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2020.10.026","volume":"183","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue. Cell 183, 1665\u20131681.e1618 (2020).","journal-title":"Cell"},{"key":"2631_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30033-z","volume":"13","author":"BF Miller","year":"2022","unstructured":"Miller, B. F. et al. Reference-free cell type deconvolution of multi-cellular pixel-resolution spatially resolved transcriptomics data. Nat. Commun. 13, 2339 (2022).","journal-title":"Nat. Commun."},{"key":"2631_CR97","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/s42255-024-01137-1","volume":"6","author":"SL Zhang","year":"2024","unstructured":"Zhang, S. L. et al. Acarbose enhances the efficacy of immunotherapy against solid tumours by modulating the gut microbiota. Nat. Metab. 6, 1991\u20132009 (2024).","journal-title":"Nat. Metab."},{"key":"2631_CR98","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","volume":"16","author":"C Mayor-Ruiz","year":"2020","unstructured":"Mayor-Ruiz, C. et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat. Chem. Biol. 16, 1199\u20131207 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2631_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.792","volume":"5","author":"S Pan","year":"2024","unstructured":"Pan, S. et al. Metabolomics-driven approaches for identifying therapeutic targets in drug discovery. MedComm 5, e792 (2024).","journal-title":"MedComm"},{"key":"2631_CR100","doi-asserted-by":"publisher","first-page":"647060","DOI":"10.3389\/fphar.2021.647060","volume":"12","author":"F Serral","year":"2021","unstructured":"Serral, F. et al. From genome to drugs: new approaches in antimicrobial discovery. Front. Pharmacol. 12, 647060 (2021).","journal-title":"Front. Pharmacol."},{"issue":"12","key":"2631_CR101","first-page":"2892","volume":"55","author":"Z Zhong-gen","year":"2020","unstructured":"Zhong-gen, Z. Advances in biosynthesis and regulation of the active ingredient of Salvia miltiorrhiza based on multi-omics approach. Acta Pharm. Sin. 55(12), 2892\u20132903 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"2631_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302459","volume":"10","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. Celastrol combats methicillin-resistant Staphylococcus aureus by targeting \u0394(1) -pyrroline-5-carboxylate dehydrogenase. Adv. Sci. 10, e2302459 (2023).","journal-title":"Adv. Sci."},{"key":"2631_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2022.104660","volume":"265","author":"NC Soares","year":"2022","unstructured":"Soares, N. C. et al. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach. J. Proteom. 265, 104660 (2022).","journal-title":"J. Proteom."},{"key":"2631_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jare.2024.11.019","volume":"75","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Glycyrrhiza, a commonly used medicinal herb: review of species classification, pharmacology, active ingredient biosynthesis, and synthetic biology. J. Adv. Res. 75, 249\u2013270 (2024).","journal-title":"J. Adv. Res."},{"key":"2631_CR105","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1039\/D4NP00018H","volume":"41","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Shi, Y. N., Xiang, H. & Shi, Y. M. Exploring nature\u2019s battlefield: organismic interactions in the discovery of bioactive natural products. Nat. Prod. Rep. 41, 1630\u20131651 (2024).","journal-title":"Nat. Prod. Rep."},{"key":"2631_CR106","doi-asserted-by":"publisher","first-page":"107366","DOI":"10.1016\/j.biotechadv.2019.03.005","volume":"37","author":"E Palazzotto","year":"2019","unstructured":"Palazzotto, E., Tong, Y., Lee, S. Y. & Weber, T. Synthetic biology and metabolic engineering of actinomycetes for natural product discovery. Biotechnol. Adv. 37, 107366 (2019).","journal-title":"Biotechnol. Adv."},{"key":"2631_CR107","doi-asserted-by":"publisher","first-page":"510","DOI":"10.7150\/thno.80066","volume":"13","author":"X Ding","year":"2023","unstructured":"Ding, X. et al. Multiple mitochondria-targeted components screened from Sini decoction improved cardiac energetics and mitochondrial dysfunction to attenuate doxorubicin-induced cardiomyopathy. Theranostics 13, 510\u2013530 (2023).","journal-title":"Theranostics"},{"key":"2631_CR108","doi-asserted-by":"publisher","first-page":"155424","DOI":"10.1016\/j.phymed.2024.155424","volume":"128","author":"C Ma","year":"2024","unstructured":"Ma, C. et al. Qijiao Shengbai Capsule alleviated leukopenia by interfering leukotriene pathway: integrated network study of multi-omics. Phytomedicine 128, 155424 (2024).","journal-title":"Phytomedicine"},{"key":"2631_CR109","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2356275","volume":"16","author":"L Cheng","year":"2024","unstructured":"Cheng, L. et al. The protective role of commensal gut microbes and their metabolites against bacterial pathogens. Gut Microbes 16, 2356275 (2024).","journal-title":"Gut Microbes"},{"key":"2631_CR110","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2438829","volume":"16","author":"J Castelo","year":"2024","unstructured":"Castelo, J. et al. The microbiota metabolite, phloroglucinol, confers long-term protection against inflammation. Gut Microbes 16, 2438829 (2024).","journal-title":"Gut Microbes"},{"key":"2631_CR111","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00018-020-03645-1","volume":"78","author":"JR Liu","year":"2021","unstructured":"Liu, J. R. et al. Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation. Cell Mol. Life Sci. 78, 909\u2013922 (2021).","journal-title":"Cell Mol. Life Sci."},{"key":"2631_CR112","doi-asserted-by":"publisher","first-page":"101530","DOI":"10.1016\/j.redox.2020.101530","volume":"34","author":"CFA Vogel","year":"2020","unstructured":"Vogel, C. F. A., Van Winkle, L. S., Esser, C. & Haarmann-Stemmann, T. The aryl hydrocarbon receptor as a target of environmental stressors\u2014 implications for pollution mediated stress and inflammatory responses. Redox Biol. 34, 101530 (2020).","journal-title":"Redox Biol."},{"key":"2631_CR113","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41564-021-01030-7","volume":"7","author":"NN Liu","year":"2022","unstructured":"Liu, N. N. et al. Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts. Nat. Microbiol 7, 238\u2013250 (2022).","journal-title":"Nat. Microbiol"},{"key":"2631_CR114","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2245562","volume":"15","author":"W Gao","year":"2023","unstructured":"Gao, W. et al. Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer. Gut Microbes 15, 2245562 (2023).","journal-title":"Gut Microbes"},{"key":"2631_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30549-4","volume":"13","author":"A Ma","year":"2022","unstructured":"Ma, A., Xin, G. & Ma, Q. The use of single-cell multi-omics in immuno-oncology. Nat. Commun. 13, 2728 (2022).","journal-title":"Nat. Commun."},{"key":"2631_CR116","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.immuni.2022.03.004","volume":"55","author":"JA Collora","year":"2022","unstructured":"Collora, J. A. et al. Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones. Immunity 55, 1013\u20131031.e1017 (2022).","journal-title":"Immunity"},{"key":"2631_CR117","doi-asserted-by":"crossref","unstructured":"Rausch, J. W. et al. HIV expression in infected T cell clones. Viruses 16, 108 (2024).","DOI":"10.3390\/v16010108"},{"key":"2631_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27716-4","volume":"13","author":"A Unterman","year":"2022","unstructured":"Unterman, A. et al. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nat. Commun. 13, 440 (2022).","journal-title":"Nat. Commun."},{"key":"2631_CR119","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41589-022-00970-3","volume":"18","author":"M Anglada-Girotto","year":"2022","unstructured":"Anglada-Girotto, M. et al. Combining CRISPRi and metabolomics for functional annotation of compound libraries. Nat. Chem. Biol. 18, 482\u2013491 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2631_CR120","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell, D. C. et al. A proteome-wide atlas of drug mechanism of action. Nat. Biotechnol. 41, 845\u2013857 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01140-9","volume":"14","author":"C Yang","year":"2022","unstructured":"Yang, C. et al. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med. 14, 140 (2022).","journal-title":"Genome Med."},{"key":"2631_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.11.017","volume":"14","author":"P Chen","year":"2024","unstructured":"Chen, P. et al. Integrated spatial metabolomics and transcriptomics decipher the hepatoprotection mechanisms of wedelolactone and demethylwedelolactone on non-alcoholic fatty liver disease. J. Pharm. Anal. 14, 100910 (2024).","journal-title":"J. Pharm. Anal."},{"key":"2631_CR123","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3358","volume":"15","author":"S Ji","year":"2023","unstructured":"Ji, S. et al. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology. Sci. Transl. Med. 15, eadg3358 (2023).","journal-title":"Sci. Transl. Med."},{"key":"2631_CR124","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1021\/jasms.3c00036","volume":"34","author":"HE Waldenmaier","year":"2023","unstructured":"Waldenmaier, H. E. et al. \u201cLab of the future\u201d\u2500today: fully automated system for high-throughput mass spectrometry analysis of biotherapeutics. J. Am. Soc. Mass Spectrom. 34, 1073\u20131085 (2023).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"2631_CR125","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4244\/EIJV17I1A2","volume":"17","author":"J Howard","year":"2021","unstructured":"Howard, J. & Reiber, J. H. C. Automated analysis of coronary angiograms using artificial intelligence: a window into the cath lab of the future. EuroIntervention 17, 16\u201317 (2021).","journal-title":"EuroIntervention"},{"key":"2631_CR126","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11427-021-1946-0","volume":"65","author":"Z Xiong","year":"2022","unstructured":"Xiong, Z. et al. Facing small and biased data dilemma in drug discovery with enhanced federated learning approaches. Sci. China Life Sci. 65, 529\u2013539 (2022).","journal-title":"Sci. China Life Sci."},{"key":"2631_CR127","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G. et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, W5\u2013w14 (2021).","journal-title":"Nucleic Acids Res."},{"key":"2631_CR128","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.70016","volume":"23","author":"J Qiao","year":"2024","unstructured":"Qiao, J. et al. AI-based R&D for frozen and thawed meat: research progress and future prospects. Compr. Rev. Food Sci. Food Saf. 23, e70016 (2024).","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"2631_CR129","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1109\/RBME.2023.3324264","volume":"17","author":"L Tong","year":"2024","unstructured":"Tong, L. et al. Integrating multi-omics data with EHR for precision medicine using advanced artificial intelligence. IEEE Rev. Biomed. Eng. 17, 80\u201397 (2024).","journal-title":"IEEE Rev. Biomed. Eng."},{"key":"2631_CR130","doi-asserted-by":"publisher","first-page":"108591","DOI":"10.1016\/j.pharmthera.2024.108591","volume":"254","author":"Z Yang","year":"2024","unstructured":"Yang, Z., Guan, F., Bronk, L. & Zhao, L. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: a multidimensional perspective. Pharm. Ther. 254, 108591 (2024).","journal-title":"Pharm. Ther."},{"key":"2631_CR131","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/bs.acr.2024.06.005","volume":"163","author":"L Li","year":"2024","unstructured":"Li, L., Sun, M., Wang, J. & Wan, S. Multi-omics based artificial intelligence for cancer research. Adv. Cancer Res. 163, 303\u2013356 (2024).","journal-title":"Adv. Cancer Res."},{"key":"2631_CR132","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.sbi.2024.102776","volume":"85","author":"Y Qiu","year":"2024","unstructured":"Qiu, Y. & Cheng, F. Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease. Curr. Opin. Struct. Biol. 85, 102776 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2631_CR133","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1021\/acsmedchemlett.5c00003","volume":"16","author":"S Choi","year":"2025","unstructured":"Choi, S., Adams, A. M. & Chibale, K. Special issue: exploring the use of AI\/ML technologies in medicinal chemistry and drug discovery. ACS Med. Chem. Lett. 16, 174 (2025).","journal-title":"ACS Med. Chem. Lett."},{"key":"2631_CR134","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2174\/1381612829666230412084137","volume":"29","author":"S Sumathi","year":"2023","unstructured":"Sumathi, S. et al. A review on deep learning-driven drug discovery: strategies, tools and applications. Curr. Pharm. Des. 29, 1013\u20131025 (2023).","journal-title":"Curr. Pharm. Des."},{"key":"2631_CR135","doi-asserted-by":"publisher","first-page":"1331062","DOI":"10.3389\/fphar.2024.1331062","volume":"15","author":"A Gangwal","year":"2024","unstructured":"Gangwal, A. et al. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities. Front. Pharmacol. 15, 1331062 (2024).","journal-title":"Front. Pharmacol."},{"key":"2631_CR136","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702.e613 (2020).","journal-title":"Cell"},{"key":"2631_CR137","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41589-023-01349-8","volume":"19","author":"G Liu","year":"2023","unstructured":"Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342\u20131350 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"2631_CR138","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1021\/acs.jcim.9b00237","volume":"59","author":"K Yang","year":"2019","unstructured":"Yang, K. et al. Analyzing learned molecular representations for property prediction. J. Chem. Inf. Model. 59, 3370\u20133388 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR139","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s43588-025-00777-x","volume":"5","author":"A Luttens","year":"2025","unstructured":"Luttens, A. et al. Rapid traversal of vast chemical space using machine learning-guided docking screens. Nat. Comput. Sci. 5, 301\u2013312 (2025).","journal-title":"Nat. Comput. Sci."},{"key":"2631_CR140","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-0716-1787-8_6","volume":"2390","author":"A Patronov","year":"2022","unstructured":"Patronov, A., Papadopoulos, K. & Engkvist, O. Has artificial intelligence impacted drug discovery? Methods Mol. Biol. 2390, 153\u2013176 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2631_CR141","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 18, 463\u2013477 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2631_CR142","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","volume":"43","author":"F Ren","year":"2025","unstructured":"Ren, F. et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat. Biotechnol. 43, 63\u201375 (2025).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR143","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","volume":"37","author":"A Zhavoronkov","year":"2019","unstructured":"Zhavoronkov, A. et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat. Biotechnol. 37, 1038\u20131040 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR144","doi-asserted-by":"crossref","unstructured":"Li, X. S. et al. Multiphysical graph neural network (MP-GNN) for COVID-19 drug design. Brief. Bioinform. 23, bbac231 (2022).","DOI":"10.1093\/bib\/bbac231"},{"key":"2631_CR145","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41596-024-01084-x","volume":"20","author":"F Wong","year":"2025","unstructured":"Wong, F. et al. An explainable deep learning platform for molecular discovery. Nat. Protoc. 20, 1020\u20131056 (2025).","journal-title":"Nat. Protoc."},{"key":"2631_CR146","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1039\/D0MO00129E","volume":"17","author":"C Fotis","year":"2021","unstructured":"Fotis, C., Meimetis, N., Sardis, A. & Alexopoulos, L. G. DeepSIBA: chemical structure-based inference of biological alterations using deep learning. Mol. Omics 17, 108\u2013120 (2021).","journal-title":"Mol. Omics"},{"key":"2631_CR147","doi-asserted-by":"publisher","first-page":"102190","DOI":"10.1016\/j.mib.2022.102190","volume":"69","author":"G Liu","year":"2022","unstructured":"Liu, G. & Stokes, J. M. A brief guide to machine learning for antibiotic discovery. Curr. Opin. Microbiol. 69, 102190 (2022).","journal-title":"Curr. Opin. Microbiol."},{"key":"2631_CR148","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-023-06887-8","volume":"626","author":"F Wong","year":"2024","unstructured":"Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177\u2013185 (2024).","journal-title":"Nature"},{"key":"2631_CR149","doi-asserted-by":"publisher","first-page":"340558","DOI":"10.1016\/j.aca.2022.340558","volume":"1244","author":"H Zhan","year":"2023","unstructured":"Zhan, H., Zhu, X., Qiao, Z. & Hu, J. Graph neural tree: a novel and interpretable deep learning-based framework for accurate molecular property predictions. Anal. Chim. Acta 1244, 340558 (2023).","journal-title":"Anal. Chim. Acta"},{"key":"2631_CR150","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1021\/acs.jcim.0c01489","volume":"61","author":"D Deng","year":"2021","unstructured":"Deng, D. et al. XGraphBoost: extracting graph neural network-based features for a better prediction of molecular properties. J. Chem. Inf. Model. 61, 2697\u20132705 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR151","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","volume":"9","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona, M., Blaschke, T., Engkvist, O. & Chen, H. Molecular de-novo design through deep reinforcement learning. J. Cheminform. 9, 48 (2017).","journal-title":"J. Cheminform."},{"key":"2631_CR152","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13321-019-0404-1","volume":"12","author":"\u0141 Maziarka","year":"2020","unstructured":"Maziarka, \u0141 et al. Mol-CycleGAN: a generative model for molecular optimization. J. Cheminform. 12, 2 (2020).","journal-title":"J. Cheminform."},{"key":"2631_CR153","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/CM9.0000000000003387","volume":"138","author":"X Tu","year":"2025","unstructured":"Tu, X. et al. Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model. Chin. Med. J. 138, 172\u2013184 (2025).","journal-title":"Chin. Med. J."},{"key":"2631_CR154","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jconrel.2024.12.043","volume":"378","author":"N Wang","year":"2025","unstructured":"Wang, N., Dong, J. & Ouyang, D. AI-directed formulation strategy design initiates rational drug development. J. Control. Release 378, 619\u2013636 (2025).","journal-title":"J. Control. Release"},{"key":"2631_CR155","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1126\/science.adx0339","volume":"388","author":"ER Gold","year":"2025","unstructured":"Gold, E. R. & Cook-Deegan, R. AI drug development\u2019s data problem. Science 388, 131 (2025).","journal-title":"Science"},{"key":"2631_CR156","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41587-021-01016-0","volume":"39","author":"D Cyranoski","year":"2021","unstructured":"Cyranoski, D. AI drug discovery booms in China. Nat. Biotechnol. 39, 900\u2013902 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR157","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43856-024-00486-y","volume":"4","author":"Y Wang","year":"2024","unstructured":"Wang, Y., Yang, Z. & Yao, Q. Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning. Commun. Med. 4, 59 (2024).","journal-title":"Commun. Med."},{"key":"2631_CR158","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s43588-023-00558-4","volume":"3","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Emerging drug interaction prediction enabled by a flow-based graph neural network with biomedical network. Nat. Comput. Sci. 3, 1023\u20131033 (2023).","journal-title":"Nat. Comput. Sci."},{"key":"2631_CR159","doi-asserted-by":"publisher","first-page":"bbae358","DOI":"10.1093\/bib\/bbae358","volume":"25","author":"F Li","year":"2024","unstructured":"Li, F. et al. DiffPROTACs is a deep learning-based generator for proteolysis targeting chimeras. Brief. Bioinform. 25, bbae358 (2024).","journal-title":"Brief. Bioinform."},{"key":"2631_CR160","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1021\/acs.jcim.4c01107","volume":"64","author":"A Alakhdar","year":"2024","unstructured":"Alakhdar, A., Poczos, B. & Washburn, N. Diffusion models in de novo drug design. J. Chem. Inf. Model. 64, 7238\u20137256 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR161","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/1873-3468.14981","volume":"598","author":"X Wei","year":"2024","unstructured":"Wei, X. et al. Fragment-based discovery of small molecule inhibitors of the HDGFRP2 PWWP domain. FEBS Lett. 598, 2533\u20132543 (2024).","journal-title":"FEBS Lett."},{"key":"2631_CR162","doi-asserted-by":"crossref","unstructured":"Wan, X. et al. An inductive graph neural network model for compound-protein interaction prediction based on a homogeneous graph. Brief. Bioinform. 23, bbac073 (2022).","DOI":"10.1093\/bib\/bbac073"},{"key":"2631_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2021.102327","volume":"73","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Graph neural network approaches for drug-target interactions. Curr. Opin. Struct. Biol. 73, 102327 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2631_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.814858","volume":"12","author":"K Han","year":"2021","unstructured":"Han, K. et al. A review of approaches for predicting drug-drug interactions based on machine learning. Front. Pharmacol. 12, 814858 (2021).","journal-title":"Front. Pharmacol."},{"key":"2631_CR165","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13321-022-00602-x","volume":"14","author":"NN Wang","year":"2022","unstructured":"Wang, N. N. et al. Machine learning to predict metabolic drug interactions related to cytochrome P450 isozymes. J. Cheminform. 14, 23 (2022).","journal-title":"J. Cheminform."},{"key":"2631_CR166","doi-asserted-by":"crossref","unstructured":"Lin, X. et al. Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction. Brief. Bioinform. 24, bbad235 (2023).","DOI":"10.1093\/bib\/bbad235"},{"key":"2631_CR167","doi-asserted-by":"crossref","unstructured":"Nyamabo, A. K., Yu, H. & Shi, J. Y. SSI-DDI: substructure-substructure interactions for drug-drug interaction prediction. Brief. Bioinform. 22, bbab133 (2021).","DOI":"10.1093\/bib\/bbab133"},{"key":"2631_CR168","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymeth.2024.01.009","volume":"223","author":"X Yan","year":"2024","unstructured":"Yan, X., Gu, C., Feng, Y. & Han, J. Predicting drug-drug interaction with graph mutual interaction attention mechanism. Methods 223, 16\u201325 (2024).","journal-title":"Methods"},{"key":"2631_CR169","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/1062936X.2019.1653966","volume":"30","author":"AV Dmitriev","year":"2019","unstructured":"Dmitriev, A. V. et al. Drug-drug interaction prediction using PASS. SAR QSAR Environ. Res. 30, 655\u2013664 (2019).","journal-title":"SAR QSAR Environ. Res."},{"key":"2631_CR170","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1021\/acs.jcim.3c01090","volume":"63","author":"M Yasir","year":"2023","unstructured":"Yasir, M. et al. Machine learning-based drug repositioning of novel janus kinase 2 inhibitors utilizing molecular docking and molecular dynamic simulation. J. Chem. Inf. Model. 63, 6487\u20136500 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR171","doi-asserted-by":"crossref","unstructured":"J, S. G., P, D. & P, E. Enhancing drug discovery in schizophrenia: a deep learning approach for accurate drug-target interaction prediction - DrugSchizoNet. Comput. Methods Biomech. Biomed. Engin. 28, 170\u2013187 (2025).","DOI":"10.1080\/10255842.2023.2282951"},{"key":"2631_CR172","doi-asserted-by":"publisher","first-page":"103294","DOI":"10.1016\/j.jbi.2019.103294","volume":"99","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Neural network-based approaches for biomedical relation classification: a review. J. Biomed. Inform. 99, 103294 (2019).","journal-title":"J. Biomed. Inform."},{"key":"2631_CR173","doi-asserted-by":"crossref","unstructured":"Shen, Z. A. et al. NPI-GNN: Predicting ncRNA-protein interactions with deep graph neural networks. Brief. Bioinform. 22, bbab051 (2021).","DOI":"10.1093\/bib\/bbab051"},{"key":"2631_CR174","doi-asserted-by":"crossref","unstructured":"Zhao, Y. et al. Drug-drug interaction prediction: databases, web servers and computational models. Brief. Bioinform. 25, bbad445 (2023).","DOI":"10.1093\/bib\/bbad445"},{"key":"2631_CR175","first-page":"5","volume":"2017","author":"R Kavuluru","year":"2017","unstructured":"Kavuluru, R., Rios, A. & Tran, T. Extracting drug-drug interactions with word and character-level recurrent neural networks. Proc. IEEE Int. Conf. Health. Inf. 2017, 5\u201312 (2017).","journal-title":"Proc. IEEE Int. Conf. Health. Inf."},{"key":"2631_CR176","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1109\/TIP.2018.2857219","volume":"28","author":"Y You","year":"2019","unstructured":"You, Y., Lu, C., Wang, W. & Tang, C. K. Relative CNN-RNN: learning relative atmospheric visibility from images. IEEE Trans. Image Process. 28, 45\u201355 (2019).","journal-title":"IEEE Trans. Image Process."},{"key":"2631_CR177","doi-asserted-by":"publisher","first-page":"102865","DOI":"10.1016\/j.artmed.2024.102865","volume":"152","author":"J Wang","year":"2024","unstructured":"Wang, J. & Guo, X. Automated detection of myocardial infarction based on an improved state refinement module for LSTM\/GRU. Artif. Intell. Med. 152, 102865 (2024).","journal-title":"Artif. Intell. Med."},{"key":"2631_CR178","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1109\/TVCG.2021.3076749","volume":"28","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Visual analytics for RNN-based deep reinforcement learning. IEEE Trans. Vis. Comput. Graph 28, 4141\u20134155 (2022).","journal-title":"IEEE Trans. Vis. Comput. Graph"},{"key":"2631_CR179","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.3389\/fpls.2019.01750","volume":"10","author":"S Khaki","year":"2019","unstructured":"Khaki, S., Wang, L. & Archontoulis, S. V. A CNN-RNN framework for crop yield prediction. Front. Plant Sci. 10, 1750 (2019).","journal-title":"Front. Plant Sci."},{"key":"2631_CR180","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jbi.2018.03.011","volume":"81","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. A hybrid model based on neural networks for biomedical relation extraction. J. Biomed. Inform. 81, 83\u201392 (2018).","journal-title":"J. Biomed. Inform."},{"key":"2631_CR181","doi-asserted-by":"publisher","first-page":"102153","DOI":"10.1016\/j.artmed.2021.102153","volume":"119","author":"D Zaikis","year":"2021","unstructured":"Zaikis, D. & Vlahavas, I. TP-DDI: transformer-based pipeline for the extraction of Drug-Drug Interactions. Artif. Intell. Med. 119, 102153 (2021).","journal-title":"Artif. Intell. Med."},{"key":"2631_CR182","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1109\/JBHI.2024.3507738","volume":"29","author":"D Zaikis","year":"2024","unstructured":"Zaikis, D. & Vlahavas, I. TransformDDI: the transformer-based joint multi-task model for end-to-end drug-drug interaction extraction. IEEE J. Biomed. Health Inform. 29, 3045\u20133056 (2024).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2631_CR183","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1002\/cpt.2887","volume":"113","author":"E J\u00e4rvinen","year":"2023","unstructured":"J\u00e4rvinen, E. et al. 3D spheroid primary human hepatocytes for prediction of cytochrome P450 and drug transporter induction. Clin. Pharmacol. Ther. 113, 1284\u20131294 (2023).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2631_CR184","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12987-023-00507-3","volume":"21","author":"R Col\u00f3n Ortiz","year":"2024","unstructured":"Col\u00f3n Ortiz, R. et al. Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier. Fluids Barriers CNS 21, 5 (2024).","journal-title":"Fluids Barriers CNS"},{"key":"2631_CR185","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13321-024-00933-x","volume":"16","author":"PY Cao","year":"2024","unstructured":"Cao, P. Y. et al. Group graph: a molecular graph representation with enhanced performance, efficiency and interpretability. J. Cheminform. 16, 133 (2024).","journal-title":"J. Cheminform."},{"key":"2631_CR186","doi-asserted-by":"publisher","first-page":"111023","DOI":"10.1016\/j.cbi.2024.111023","volume":"395","author":"H Yin","year":"2024","unstructured":"Yin, H. et al. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions. Chem. Biol. Interact. 395, 111023 (2024).","journal-title":"Chem. Biol. Interact."},{"key":"2631_CR187","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/dmd.105.006874","volume":"34","author":"A Galetin","year":"2006","unstructured":"Galetin, A., Burt, H., Gibbons, L. & Houston, J. B. Prediction of time-dependent CYP3A4 drug-drug interactions: impact of enzyme degradation, parallel elimination pathways, and intestinal inhibition. Drug Metab. Dispos. 34, 166\u2013175 (2006).","journal-title":"Drug Metab. Dispos."},{"key":"2631_CR188","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1124\/dmd.118.081364","volume":"46","author":"L Prieto Garcia","year":"2018","unstructured":"Prieto Garcia, L. et al. Physiologically based pharmacokinetic model of itraconazole and two of its metabolites to improve the predictions and the mechanistic understanding of CYP3A4 drug-drug interactions. Drug Metab. Dispos. 46, 1420\u20131433 (2018).","journal-title":"Drug Metab. Dispos."},{"key":"2631_CR189","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1021\/acs.jcim.4c02122","volume":"65","author":"H Han","year":"2025","unstructured":"Han, H. et al. Employing automated machine learning (AutoML) methods to facilitate the in silico ADMET properties prediction. J. Chem. Inf. Model. 65, 3215\u20133225 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR190","doi-asserted-by":"crossref","unstructured":"Menestrina, L. et al. Refined ADME profiles for ATC drug classes. Pharmaceutics. 17, 308 (2025).","DOI":"10.3390\/pharmaceutics17030308"},{"key":"2631_CR191","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acs.chemrestox.9b00264","volume":"33","author":"DP Williams","year":"2020","unstructured":"Williams, D. P. et al. Predicting drug-induced liver injury with Bayesian machine learning. Chem. Res. Toxicol. 33, 239\u2013248 (2020).","journal-title":"Chem. Res. Toxicol."},{"key":"2631_CR192","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2020.100133","volume":"16","author":"E Semenova","year":"2020","unstructured":"Semenova, E., Afzal, W. D. & Lazic, A. M. SE. A Bayesian neural network for toxicity prediction. Comput. Toxicol. 16, 100133 (2020).","journal-title":"Comput. Toxicol."},{"key":"2631_CR193","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/978-1-0716-1787-8_22","volume":"2390","author":"GF Smith","year":"2022","unstructured":"Smith, G. F. Artificial intelligence in drug safety and metabolism. Methods Mol. Biol. 2390, 483\u2013501 (2022).","journal-title":"Methods Mol. Biol."},{"key":"2631_CR194","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fphar.2020.00639","volume":"11","author":"P Mamoshina","year":"2020","unstructured":"Mamoshina, P., Bueno-Orovio, A. & Rodriguez, B. Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity. Front. Pharmacol. 11, 639 (2020).","journal-title":"Front. Pharmacol."},{"key":"2631_CR195","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/jat.3741","volume":"39","author":"F Hammann","year":"2019","unstructured":"Hammann, F., Sch\u00f6ning, V. & Drewe, J. Prediction of clinically relevant drug-induced liver injury from structure using machine learning. J. Appl. Toxicol. 39, 412\u2013419 (2019).","journal-title":"J. Appl. Toxicol."},{"key":"2631_CR196","doi-asserted-by":"publisher","first-page":"104122","DOI":"10.1016\/j.jbi.2022.104122","volume":"132","author":"PVM Joshi","year":"2022","unstructured":"Joshi, P. V. M. & Mukherjee, A. A knowledge graph embedding based approach to predict the adverse drug reactions using a deep neural network. J. Biomed. Inform. 132, 104122 (2022).","journal-title":"J. Biomed. Inform."},{"key":"2631_CR197","doi-asserted-by":"crossref","unstructured":"Rao, M. et al. Artificial intelligence and machine learning models for predicting drug-induced kidney injury in small molecules. Pharmaceuticals 17, 1550 (2024).","DOI":"10.3390\/ph17111550"},{"key":"2631_CR198","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1016\/j.apsb.2024.03.002","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. In silico off-target profiling for enhanced drug safety assessment. Acta Pharm. Sin. B 14, 2927\u20132941 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"2631_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104009","volume":"29","author":"M Kp Jayatunga","year":"2024","unstructured":"Kp Jayatunga, M. et al. How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons. Drug Discov. Today 29, 104009 (2024).","journal-title":"Drug Discov. Today"},{"key":"2631_CR200","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41589-024-01679-1","volume":"20","author":"DB Catacutan","year":"2024","unstructured":"Catacutan, D. B., Alexander, J., Arnold, A. & Stokes, J. M. Machine learning in preclinical drug discovery. Nat. Chem. Biol. 20, 960\u2013973 (2024).","journal-title":"Nat. Chem. Biol."},{"key":"2631_CR201","doi-asserted-by":"publisher","first-page":"bbac408","DOI":"10.1093\/bib\/bbac408","volume":"23","author":"H Cai","year":"2022","unstructured":"Cai, H. et al. FP-GNN: a versatile deep learning architecture for enhanced molecular property prediction. Brief. Bioinform. 23, bbac408 (2022).","journal-title":"Brief. Bioinform."},{"key":"2631_CR202","doi-asserted-by":"publisher","first-page":"689493","DOI":"10.3389\/fmicb.2021.689493","volume":"12","author":"EC Ashe","year":"2021","unstructured":"Ashe, E. C., Comeau, A. M., Zejdlik, K. & O\u2019Connell, S. P. Characterization of bacterial community dynamics of the human mouth throughout decomposition via metagenomic, metatranscriptomic, and culturing techniques. Front. Microbiol. 12, 689493 (2021).","journal-title":"Front. Microbiol."},{"key":"2631_CR203","doi-asserted-by":"crossref","unstructured":"Zhai, Y., Chen, L. & Deng, M. scGAD: a new task and end-to-end framework for generalized cell type annotation and discovery. Brief. Bioinform. 24, bbad045 (2023).","DOI":"10.1093\/bib\/bbad045"},{"key":"2631_CR204","doi-asserted-by":"crossref","unstructured":"Wang, B. et al. STCGAN: a novel cycle-consistent generative adversarial network for spatial transcriptomics cellular deconvolution. Brief. Bioinform. 26, bbae670 (2024).","DOI":"10.1093\/bib\/bbae670"},{"key":"2631_CR205","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13321-025-00959-9","volume":"17","author":"ME Mswahili","year":"2025","unstructured":"Mswahili, M. E. et al. Positional embeddings and zero-shot learning using BERT for molecular-property prediction. J. Cheminform. 17, 17 (2025).","journal-title":"J. Cheminform."},{"key":"2631_CR206","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/s41592-024-02305-7","volume":"21","author":"M Hao","year":"2024","unstructured":"Hao, M. et al. Large-scale foundation model on single-cell transcriptomics. Nat. Methods 21, 1481\u20131491 (2024).","journal-title":"Nat. Methods"},{"key":"2631_CR207","doi-asserted-by":"crossref","unstructured":"Zhai, Y., Chen, L. & Deng, M. scBOL: a universal cell type identification framework for single-cell and spatial transcriptomics data. Brief. Bioinform. 25, bbae188 (2024).","DOI":"10.1093\/bib\/bbae188"},{"key":"2631_CR208","doi-asserted-by":"publisher","first-page":"bbae305","DOI":"10.1093\/bib\/bbae305","volume":"25","author":"Q Guo","year":"2024","unstructured":"Guo, Q., Yuan, M., Zhang, L. & Deng, M. scPLAN: a hierarchical computational framework for single transcriptomics data annotation, integration and cell-type label refinement. Brief. Bioinform. 25, bbae305 (2024).","journal-title":"Brief. Bioinform."},{"key":"2631_CR209","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/j.gastro.2025.02.035","volume":"169","author":"T Rozera","year":"2025","unstructured":"Rozera, T., Pasolli, E., Segata, N. & Ianiro, G. Machine learning and artificial intelligence in the multi-omics approach to gut microbiota. Gastroenterology. 169, 487\u2013501 (2025).","journal-title":"Gastroenterology."},{"key":"2631_CR210","doi-asserted-by":"publisher","first-page":"1434799","DOI":"10.3389\/fmedt.2024.1434799","volume":"6","author":"TC Dakal","year":"2024","unstructured":"Dakal, T. C., Xu, C. & Kumar, A. Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification. Front. Med. Technol. 6, 1434799 (2024).","journal-title":"Front. Med. Technol."},{"key":"2631_CR211","doi-asserted-by":"crossref","unstructured":"Majidova, K. et al. Role of digital health and artificial intelligence in inflammatory bowel disease: a scoping review. Genes 12, 1465 (2021).","DOI":"10.3390\/genes12101465"},{"key":"2631_CR212","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1038\/s41591-024-03280-4","volume":"30","author":"J Zheng","year":"2024","unstructured":"Zheng, J. et al. Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. Nat. Med. 30, 3555\u20133567 (2024).","journal-title":"Nat. Med."},{"key":"2631_CR213","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2147\/JIR.S306816","volume":"14","author":"Q Huang","year":"2021","unstructured":"Huang, Q., Zhang, X. & Hu, Z. Application of artificial intelligence modeling technology based on multi-omics in noninvasive diagnosis of inflammatory bowel disease. J. Inflamm. Res. 14, 1933\u20131943 (2021).","journal-title":"J. Inflamm. Res."},{"key":"2631_CR214","doi-asserted-by":"publisher","first-page":"119686","DOI":"10.1016\/j.cca.2024.119686","volume":"559","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. Precision medicine in colorectal cancer: leveraging multi-omics, spatial omics, and artificial intelligence. Clin. Chim. Acta 559, 119686 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"2631_CR215","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.ccell.2021.04.002","volume":"39","author":"BH Kann","year":"2021","unstructured":"Kann, B. H., Hosny, A. & Aerts, H. Artificial intelligence for clinical oncology. Cancer Cell 39, 916\u2013927 (2021).","journal-title":"Cancer Cell"},{"key":"2631_CR216","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02165-7","volume":"21","author":"I Tanaka","year":"2021","unstructured":"Tanaka, I., Furukawa, T. & Morise, M. The current issues and future perspective of artificial intelligence for developing new treatment strategy in non-small cell lung cancer: harmonization of molecular cancer biology and artificial intelligence. Cancer Cell Int. 21, 454 (2021).","journal-title":"Cancer Cell Int."},{"key":"2631_CR217","doi-asserted-by":"crossref","unstructured":"Barroso, R. A. et al. Unlocking antimicrobial peptides: in silico proteolysis and artificial intelligence-driven discovery from cnidarian omics. Molecules. 30, 550 (2025).","DOI":"10.3390\/molecules30030550"},{"key":"2631_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50453-3","volume":"15","author":"J Feng","year":"2024","unstructured":"Feng, J. et al. A synthetic antibiotic class with a deeply-optimized design for overcoming bacterial resistance. Nat. Commun. 15, 6040 (2024).","journal-title":"Nat. Commun."},{"key":"2631_CR219","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS Oh","year":"2023","unstructured":"Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"2631_CR220","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.molmed.2024.01.005","volume":"30","author":"MR Duggan","year":"2024","unstructured":"Duggan, M. R. & Walker, K. A. Organ-specific aging in the plasma proteome predicts disease. Trends Mol. Med. 30, 423\u2013424 (2024).","journal-title":"Trends Mol. Med."},{"key":"2631_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561544","volume":"16","author":"T Li","year":"2025","unstructured":"Li, T. et al. Integrating machine learning and multi-omics analysis to reveal nucleotide metabolism-related immune genes and their functional validation in ischemic stroke. Front. Immunol. 16, 1561544 (2025).","journal-title":"Front. Immunol."},{"key":"2631_CR222","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77495-3","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Integrating machine learning and single-cell transcriptomic analysis to identify potential biomarkers and analyze immune features of ischemic stroke. Sci. Rep. 14, 26069 (2024).","journal-title":"Sci. Rep."},{"key":"2631_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.07.009","volume":"311","author":"M Hebron","year":"2017","unstructured":"Hebron, M. et al. Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models. J. Neuroimmunol. 311, 1\u20139 (2017).","journal-title":"J. Neuroimmunol."},{"key":"2631_CR224","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1021\/acschemneuro.7b00308","volume":"9","author":"S Kortagere","year":"2018","unstructured":"Kortagere, S. et al. Identification of novel allosteric modulators of glutamate transporter EAAT2. ACS Chem. Neurosci. 9, 522\u2013534 (2018).","journal-title":"ACS Chem. Neurosci."},{"key":"2631_CR225","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1021\/acscentsci.7b00303","volume":"3","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. Retrosynthetic reaction prediction using neural sequence-to-sequence models. ACS Cent. Sci. 3, 1103\u20131113 (2017).","journal-title":"ACS Cent. Sci."},{"key":"2631_CR226","doi-asserted-by":"publisher","first-page":"6155","DOI":"10.1038\/s41467-023-41698-5","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Retrosynthesis prediction with an interpretable deep-learning framework based on molecular assembly tasks. Nat. Commun. 14, 6155 (2023).","journal-title":"Nat. Commun."},{"key":"2631_CR227","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.tjpad.2025.100128","volume":"12","author":"J Hu","year":"2025","unstructured":"Hu, J., Luo, Y. & Wang, X. Multi-omics analysis of druggable genes to facilitate Alzheimer\u2019s disease therapy: a multi-cohort machine learning study. J. Prev. Alzheimers Dis. 12, 100128 (2025).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"2631_CR228","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement. 9, e12385 (2023).","journal-title":"Alzheimers Dement."},{"key":"2631_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21330-0","volume":"12","author":"S Rodriguez","year":"2021","unstructured":"Rodriguez, S. et al. Machine learning identifies candidates for drug repurposing in Alzheimer\u2019s disease. Nat. Commun. 12, 1033 (2021).","journal-title":"Nat. Commun."},{"key":"2631_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101379","volume":"5","author":"F Cheng","year":"2024","unstructured":"Cheng, F. et al. Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer\u2019s disease. Cell Rep. Med. 5, 101379 (2024).","journal-title":"Cell Rep. Med."},{"key":"2631_CR231","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13195-020-00760-w","volume":"13","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer\u2019s drug discovery. Alzheimers Res. Ther. 13, 24 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"2631_CR232","doi-asserted-by":"publisher","first-page":"108604","DOI":"10.1016\/j.cmpb.2025.108604","volume":"261","author":"NA Zulhafiz","year":"2025","unstructured":"Zulhafiz, N. A., Teoh, T. C., Chin, A. V. & Chang, S. W. Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: a comprehensive review in general diseases vs Alzheimer\u2019s disease. Comput. Methods Prog. Biomed. 261, 108604 (2025).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"2631_CR233","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411325","volume":"12","author":"Z Wan","year":"2025","unstructured":"Wan, Z. et al. Applications of artificial intelligence in drug repurposing. Adv. Sci. 12, e2411325 (2025).","journal-title":"Adv. Sci."},{"key":"2631_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85947-7","volume":"15","author":"VOK Li","year":"2025","unstructured":"Li, V. O. K. et al. DeepDrug as an expert guided and AI driven drug repurposing methodology for selecting the lead combination of drugs for Alzheimer\u2019s disease. Sci. Rep. 15, 2093 (2025).","journal-title":"Sci. Rep."},{"key":"2631_CR235","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.cell.2021.03.032","volume":"184","author":"MK Shin","year":"2021","unstructured":"Shin, M. K. et al. Reducing acetylated tau is neuroprotective in brain injury. Cell 184, 2715\u20132732.e2723 (2021).","journal-title":"Cell"},{"key":"2631_CR236","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"21","author":"SW Min","year":"2015","unstructured":"Min, S. W. et al. Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat. Med. 21, 1154\u20131162 (2015).","journal-title":"Nat. Med."},{"key":"2631_CR237","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s43587-021-00138-z","volume":"1","author":"J Fang","year":"2021","unstructured":"Fang, J. et al. Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer\u2019s disease. Nat. Aging 1, 1175\u20131188 (2021).","journal-title":"Nat. Aging"},{"key":"2631_CR238","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.tips.2019.06.003","volume":"40","author":"MD Paranjpe","year":"2019","unstructured":"Paranjpe, M. D., Taubes, A. & Sirota, M. Insights into computational drug repurposing for neurodegenerative disease. Trends Pharmacol. Sci. 40, 565\u2013576 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"2631_CR239","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01828-w","volume":"25","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine. J. Headache Pain. 25, 117 (2024).","journal-title":"J. Headache Pain."},{"key":"2631_CR240","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413405","volume":"12","author":"C Bai","year":"2025","unstructured":"Bai, C. et al. Machine learning-enabled drug-induced toxicity prediction. Adv. Sci. 12, e2413405 (2025).","journal-title":"Adv. Sci."},{"key":"2631_CR241","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.05.011","volume":"75","author":"AS Monzel","year":"2020","unstructured":"Monzel, A. S. et al. Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism Relat. Disord. 75, 105\u2013109 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"2631_CR242","first-page":"293","volume":"2019","author":"F Kuusisto","year":"2019","unstructured":"Kuusisto, F. et al. Machine learning to predict developmental neurotoxicity with high-throughput data from 2D bio-engineered tissues. Proc. Int. Conf. Mach. Learn. Appl. 2019, 293\u2013298 (2019).","journal-title":"Proc. Int. Conf. Mach. Learn. Appl."},{"key":"2631_CR243","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1021\/acs.jcim.2c01131","volume":"62","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. Machine learning modeling and insights into the structural characteristics of drug-induced neurotoxicity. J. Chem. Inf. Model. 62, 6035\u20136045 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR244","doi-asserted-by":"crossref","unstructured":"Lee, B. et al. A deep learning approach with data augmentation to predict novel spider neurotoxic peptides. Int. J. Mol. Sci. 22, 12291 (2021).","DOI":"10.3390\/ijms222212291"},{"key":"2631_CR245","first-page":"1477870","volume":"3","author":"X Zeng","year":"2022","unstructured":"Zeng, X. et al. Accurate prediction of molecular targets using a self-supervised image representation learning framework. Res. Sq. 3, 1477870 (2022).","journal-title":"Res. Sq."},{"key":"2631_CR246","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10928-021-09787-4","volume":"49","author":"J Parikh","year":"2022","unstructured":"Parikh, J. et al. Generative adversarial networks for construction of virtual populations of mechanistic models: simulations to study Omecamtiv Mecarbil action. J. Pharmacokinet. Pharmacodyn. 49, 51\u201364 (2022).","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"2631_CR247","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/cts.12491","volume":"11","author":"J Cummings","year":"2018","unstructured":"Cummings, J. Lessons learned from Alzheimer disease: clinical trials with negative outcomes. Clin. Transl. Sci. 11, 147\u2013152 (2018).","journal-title":"Clin. Transl. Sci."},{"key":"2631_CR248","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/bioinformatics\/btaa918","volume":"37","author":"B Shaker","year":"2021","unstructured":"Shaker, B. et al. LightBBB: computational prediction model of blood-brain-barrier penetration based on LightGBM. Bioinformatics 37, 1135\u20131139 (2021).","journal-title":"Bioinformatics"},{"key":"2631_CR249","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2174\/1389201020666190821145346","volume":"20","author":"D Saxena","year":"2019","unstructured":"Saxena, D., Sharma, A., Siddiqui, M. H. & Kumar, R. Blood brain barrier permeability prediction using machine learning techniques: an update. Curr. Pharm. Biotechnol. 20, 1163\u20131171 (2019).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"2631_CR250","doi-asserted-by":"publisher","first-page":"31784","DOI":"10.1021\/acsomega.3c02799","volume":"8","author":"H Nada","year":"2023","unstructured":"Nada, H. et al. Machine learning-based approach to developing potent EGFR inhibitors for breast cancer-design, synthesis, and in vitro evaluation. ACS Omega 8, 31784\u201331800 (2023).","journal-title":"ACS Omega"},{"key":"2631_CR251","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110559","volume":"194","author":"A Bararia","year":"2025","unstructured":"Bararia, A. et al. A multi-phase approach using supervised algorithms and clinical models to generate high-accuracy signatures for pancreatic cancer. Comput. Biol. Med. 194, 110559 (2025).","journal-title":"Comput. Biol. Med."},{"key":"2631_CR252","doi-asserted-by":"publisher","first-page":"110432","DOI":"10.1016\/j.compbiomed.2025.110432","volume":"193","author":"S Sharma","year":"2025","unstructured":"Sharma, S., Singh, R., Kant, S. & Mishra, M. K. Integrating AI\/ML and multi-omics approaches to investigate the role of TNFRSF10A\/TRAILR1 and its potential targets in pancreatic cancer. Comput. Biol. Med. 193, 110432 (2025).","journal-title":"Comput. Biol. Med."},{"key":"2631_CR253","doi-asserted-by":"publisher","first-page":"1572034","DOI":"10.3389\/fimmu.2025.1572034","volume":"16","author":"H Yan","year":"2025","unstructured":"Yan, H., Ji, X. & Li, B. Advancing personalized, predictive, and preventive medicine in bladder cancer: a multi-omics and machine learning approach for novel prognostic modeling, immune profiling, and therapeutic target discovery. Front. Immunol. 16, 1572034 (2025).","journal-title":"Front. Immunol."},{"key":"2631_CR254","doi-asserted-by":"publisher","first-page":"i446","DOI":"10.1093\/bioinformatics\/btz342","volume":"35","author":"A Cheerla","year":"2019","unstructured":"Cheerla, A. & Gevaert, O. Deep learning with multimodal representation for pancancer prognosis prediction. Bioinformatics 35, i446\u2013i454 (2019).","journal-title":"Bioinformatics"},{"key":"2631_CR255","doi-asserted-by":"publisher","first-page":"588221","DOI":"10.3389\/fonc.2020.588221","volume":"10","author":"N Biswas","year":"2020","unstructured":"Biswas, N. & Chakrabarti, S. Artificial intelligence (AI)-based systems biology approaches in multi-omics data analysis of cancer. Front. Oncol. 10, 588221 (2020).","journal-title":"Front. Oncol."},{"key":"2631_CR256","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu, X. et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct. Target Ther. 9, 170 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"2631_CR257","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.62347\/UZGP9704","volume":"14","author":"Z He","year":"2024","unstructured":"He, Z. et al. Multi-omics and tumor immune microenvironment characterization of a prognostic model based on aging-related genes in melanoma. Am. J. Cancer Res. 14, 1052\u20131070 (2024).","journal-title":"Am. J. Cancer Res."},{"key":"2631_CR258","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28372-y","volume":"13","author":"N Abdelfattah","year":"2022","unstructured":"Abdelfattah, N. et al. Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat. Commun. 13, 767 (2022).","journal-title":"Nat. Commun."},{"key":"2631_CR259","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apcsb.2023.11.008","volume":"139","author":"S Mehrotra","year":"2024","unstructured":"Mehrotra, S., Sharma, S. & Pandey, R. K. A journey from omics to clinicomics in solid cancers: success stories and challenges. Adv. Protein Chem. Struct. Biol. 139, 89\u2013139 (2024).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"2631_CR260","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1021\/acsomega.2c06659","volume":"8","author":"PA Patkulkar","year":"2023","unstructured":"Patkulkar, P. A., Subbalakshmi, A. R., Jolly, M. K. & Sinharay, S. Mapping spatiotemporal heterogeneity in tumor profiles by integrating high-throughput imaging and omics analysis. ACS Omega 8, 6126\u20136138 (2023).","journal-title":"ACS Omega"},{"key":"2631_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54710-3","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng, Y. et al. Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients. Nat. Commun. 15, 10259 (2024).","journal-title":"Nat. Commun."},{"key":"2631_CR262","doi-asserted-by":"crossref","unstructured":"Cembrowska-Lech, D. et al. An integrated multi-omics and artificial intelligence framework for advance plant phenotyping in horticulture. Biology 12, 1298 (2023).","DOI":"10.3390\/biology12101298"},{"key":"2631_CR263","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00385","volume":"9","author":"M Imai","year":"2025","unstructured":"Imai, M. et al. Artificial intelligence-powered human epidermal growth factor receptor 2 and tumor microenvironment analysis in human epidermal growth factor receptor 2-amplified metastatic colorectal cancer: exploratory analysis of phase II TRIUMPH trial. JCO Precis. Oncol. 9, e2400385 (2025).","journal-title":"JCO Precis. Oncol."},{"key":"2631_CR264","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00636-2","volume":"12","author":"H Kumar","year":"2022","unstructured":"Kumar, H. et al. secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics. Blood Cancer J. 12, 39 (2022).","journal-title":"Blood Cancer J."},{"key":"2631_CR265","volume":"2022","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Integrating radiomics with genomics for non-small cell lung cancer survival analysis. J. Oncol. 2022, 5131170 (2022).","journal-title":"J. Oncol."},{"key":"2631_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114392","volume":"43","author":"C Quek","year":"2024","unstructured":"Quek, C. et al. Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy. Cell Rep. 43, 114392 (2024).","journal-title":"Cell Rep."},{"key":"2631_CR267","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.7150\/ijms.107694","volume":"22","author":"T Hu","year":"2025","unstructured":"Hu, T. et al. Multi-omics and single-cell analysis reveals machine learning-based pyrimidine metabolism-related signature in the prognosis of patients with lung adenocarcinoma. Int. J. Med. Sci. 22, 1375\u20131392 (2025).","journal-title":"Int. J. Med. Sci."},{"key":"2631_CR268","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55914-x","volume":"16","author":"Z Kan","year":"2025","unstructured":"Kan, Z. et al. Real-world clinical multi-omics analyses reveal bifurcation of ER-independent and ER-dependent drug resistance to CDK4\/6 inhibitors. Nat. Commun. 16, 932 (2025).","journal-title":"Nat. Commun."},{"key":"2631_CR269","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10565-024-09880-7","volume":"40","author":"VPW Au Yeung","year":"2024","unstructured":"Au Yeung, V. P. W. et al. Computational approaches identify a transcriptomic fingerprint of drug-induced structural cardiotoxicity. Cell Biol. Toxicol. 40, 50 (2024).","journal-title":"Cell Biol. Toxicol."},{"key":"2631_CR270","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1021\/acssensors.4c00654","volume":"9","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. Two-dimensional deep learning frameworks for drug-induced cardiotoxicity detection. ACS Sens 9, 3316\u20133326 (2024).","journal-title":"ACS Sens"},{"key":"2631_CR271","doi-asserted-by":"publisher","first-page":"107812","DOI":"10.1016\/j.compbiomed.2023.107812","volume":"169","author":"L Yu","year":"2024","unstructured":"Yu, L., Xu, Z., Qiu, W. & Xiao, X. MSDSE: predicting drug-side effects based on multi-scale features and deep multi-structure neural network. Comput. Biol. Med. 169, 107812 (2024).","journal-title":"Comput. Biol. Med."},{"key":"2631_CR272","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1109\/TCBB.2022.3141103","volume":"20","author":"OC Uner","year":"2023","unstructured":"Uner, O. C. et al. DeepSide: a deep learning approach for drug side effect prediction. IEEE\/ACM Trans. Comput. Biol. Bioinform. 20, 330\u2013339 (2023).","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"2631_CR273","doi-asserted-by":"crossref","unstructured":"Wei, J. et al. GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning. Brief. Bioinform. 24, bbad247 (2023).","DOI":"10.1093\/bib\/bbad247"},{"key":"2631_CR274","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41551-021-00699-9","volume":"5","author":"DM Mason","year":"2021","unstructured":"Mason, D. M. et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nat. Biomed. Eng. 5, 600\u2013612 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"2631_CR275","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s43018-024-00756-7","volume":"5","author":"S Sinha","year":"2024","unstructured":"Sinha, S. et al. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nat. Cancer 5, 938\u2013952 (2024).","journal-title":"Nat. Cancer"},{"key":"2631_CR276","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","volume":"18","author":"A Joshi","year":"2021","unstructured":"Joshi, A., Rienks, M., Theofilatos, K. & Mayr, M. Systems biology in cardiovascular disease: a multiomics approach. Nat. Rev. Cardiol. 18, 313\u2013330 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"2631_CR277","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01282-y","volume":"16","author":"P Kiessling","year":"2024","unstructured":"Kiessling, P. & Kuppe, C. Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases. Genome Med. 16, 14 (2024).","journal-title":"Genome Med."},{"key":"2631_CR278","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-023-05844-9","volume":"616","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. An atlas of genetic scores to predict multi-omic traits. Nature 616, 123\u2013131 (2023).","journal-title":"Nature"},{"key":"2631_CR279","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2023.08.053","volume":"82","author":"W Ouwerkerk","year":"2023","unstructured":"Ouwerkerk, W. et al. Multiomics analysis provides novel pathways related to progression of heart failure. J. Am. Coll. Cardiol. 82, 1921\u20131931 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2631_CR280","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl5654","volume":"14","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy. Sci. Transl. Med. 14, eabl5654 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2631_CR281","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","volume":"618","author":"CV Theodoris","year":"2023","unstructured":"Theodoris, C. V. et al. Transfer learning enables predictions in network biology. Nature 618, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"2631_CR282","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s12539-022-00521-3","volume":"14","author":"H Shi","year":"2022","unstructured":"Shi, H. & Zhang, S. Accurate prediction of anti-hypertensive peptides based on convolutional neural network and gated recurrent unit. Interdiscip. Sci. 14, 879\u2013894 (2022).","journal-title":"Interdiscip. Sci."},{"key":"2631_CR283","doi-asserted-by":"crossref","unstructured":"Ma, C., Zhou, Z., Liu, H. & Koslicki, D. KGML-xDTD: a knowledge graph-based machine learning framework for drug treatment prediction and mechanism description. Gigascience 12, giad057 (2022).","DOI":"10.1093\/gigascience\/giad057"},{"key":"2631_CR284","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1161\/CIRCGENETICS.109.899443","volume":"3","author":"M Preuss","year":"2010","unstructured":"Preuss, M. et al. Design of the coronary artery disease genome-wide replication and meta-analysis (CARDIoGRAM) study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ. Cardiovasc. Genet. 3, 475\u2013483 (2010).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2631_CR285","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nature09266","volume":"466","author":"K Musunuru","year":"2010","unstructured":"Musunuru, K. et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714\u2013719 (2010).","journal-title":"Nature"},{"key":"2631_CR286","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2009.06.034","volume":"208","author":"P Linsel-Nitschke","year":"2010","unstructured":"Linsel-Nitschke, P. et al. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 208, 183\u2013189 (2010).","journal-title":"Atherosclerosis"},{"key":"2631_CR287","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10, 57\u201363 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"2631_CR288","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/CIRCGENETICS.113.000129","volume":"7","author":"PY Wu","year":"2014","unstructured":"Wu, P. Y. et al. Cardiovascular transcriptomics and epigenomics using next-generation sequencing: challenges, progress, and opportunities. Circ. Cardiovasc. Genet. 7, 701\u2013710 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2631_CR289","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.aay0256","volume":"366","author":"P Mohammadi","year":"2019","unstructured":"Mohammadi, P. et al. Genetic regulatory variation in populations informs transcriptome analysis in rare disease. Science 366, 351\u2013356 (2019).","journal-title":"Science"},{"key":"2631_CR290","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1126\/science.aad6970","volume":"353","author":"O Franz\u00e9n","year":"2016","unstructured":"Franz\u00e9n, O. et al. Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases. Science 353, 827\u2013830 (2016).","journal-title":"Science"},{"key":"2631_CR291","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"Human genomics","year":"2015","unstructured":"Human genomics The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660 (2015).","journal-title":"Science"},{"key":"2631_CR292","doi-asserted-by":"publisher","first-page":"e069116","DOI":"10.1136\/bmj-2021-069116","volume":"377","author":"SU Khan","year":"2022","unstructured":"Khan, S. U. et al. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ 377, e069116 (2022).","journal-title":"BMJ"},{"key":"2631_CR293","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03876-3","volume":"21","author":"ZH Ren","year":"2023","unstructured":"Ren, Z. H. et al. DeepMPF: deep learning framework for predicting drug-target interactions based on multi-modal representation with meta-path semantic analysis. J. Transl. Med. 21, 48 (2023).","journal-title":"J. Transl. Med."},{"key":"2631_CR294","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-6-114","volume":"6","author":"A Karlst\u00e4dt","year":"2012","unstructured":"Karlst\u00e4dt, A. et al. CardioNet: a human metabolic network suited for the study of cardiomyocyte metabolism. BMC Syst. Biol. 6, 114 (2012).","journal-title":"BMC Syst. Biol."},{"key":"2631_CR295","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCGENETICS.113.000269","volume":"7","author":"LM Edwards","year":"2014","unstructured":"Edwards, L. M. et al. Genome-scale methods converge on key mitochondrial genes for the survival of human cardiomyocytes in hypoxia. Circ. Cardiovasc. Genet. 7, 407\u2013415 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"2631_CR296","doi-asserted-by":"crossref","unstructured":"Zong, N. et al. Advancing efficacy prediction for EHR-based emulated trials in repurposing heart failure therapies. NPJ Digit. Med. 8, 306 (2025).","DOI":"10.1038\/s41746-025-01705-z"},{"key":"2631_CR297","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.gim.2022.01.022","volume":"24","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: the Mayo-Baylor RIGHT 10K Study. Genet. Med. 24, 1062\u20131072 (2022).","journal-title":"Genet. Med."},{"key":"2631_CR298","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jare.2023.11.025","volume":"64","author":"H Tan","year":"2024","unstructured":"Tan, H. et al. Machine learning approach reveals microbiome, metabolome, and lipidome profiles in type 1 diabetes. J. Adv. Res. 64, 213\u2013221 (2024).","journal-title":"J. Adv. Res."},{"key":"2631_CR299","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41587-023-01805-9","volume":"41","author":"RL Alles\u00f8e","year":"2023","unstructured":"Alles\u00f8e, R. L. et al. Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models. Nat. Biotechnol. 41, 1026 (2023).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR300","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00125-024-06339-6","volume":"68","author":"MR Shapiro","year":"2025","unstructured":"Shapiro, M. R. et al. Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes. Diabetologia 68, 477\u2013494 (2025).","journal-title":"Diabetologia"},{"key":"2631_CR301","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/humupd\/dmaf002","volume":"31","author":"F Zhang","year":"2025","unstructured":"Zhang, F. et al. Harnessing omics data for drug discovery and development in ovarian aging. Hum. Reprod. Update 31, 240\u2013268 (2025).","journal-title":"Hum. Reprod. Update"},{"key":"2631_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117825","volume":"295","author":"AS Jusoh","year":"2025","unstructured":"Jusoh, A. S. et al. How generative artificial intelligence can transform drug discovery? Eur. J. Med. Chem. 295, 117825 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"2631_CR303","doi-asserted-by":"crossref","unstructured":"Rabaan, A. A. et al. Omics approaches in drug development against leishmaniasis: current scenario and future prospects. Pathogens 12, 39 (2022).","DOI":"10.3390\/pathogens12010039"},{"key":"2631_CR304","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay, M. et al. Clinical development success rates for investigational drugs. Nat. Biotechnol. 32, 40\u201351 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2631_CR305","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","volume":"40","author":"S Harrer","year":"2019","unstructured":"Harrer, S., Shah, P., Antony, B. & Hu, J. Artificial intelligence for clinical trial design. Trends Pharmacol. Sci. 40, 577\u2013591 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"2631_CR306","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jamia\/ocz064","volume":"26","author":"J Gligorijevic","year":"2019","unstructured":"Gligorijevic, J. et al. Optimizing clinical trials recruitment via deep learning. J. Am. Med. Inform. Assoc. 26, 1195\u20131202 (2019).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"2631_CR307","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel, D. B. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp. Clin. Trials Commun. 11, 156\u2013164 (2018).","journal-title":"Contemp. Clin. Trials Commun."},{"key":"2631_CR308","unstructured":"Persidis, A. The benefits of drug repositioning. Drug Discov. World 12, 9\u201312 (2011)."},{"key":"2631_CR309","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/bimj.201900232","volume":"62","author":"A Baldi Antognini","year":"2020","unstructured":"Baldi Antognini, A., Novelli, M., Zagoraiou, M. & Vagheggini, A. Compound optimal allocations for survival clinical trials. Biom. J. 62, 1730\u20131746 (2020).","journal-title":"Biom. J."},{"key":"2631_CR310","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semradonc.2023.06.001","volume":"33","author":"S Perni","year":"2023","unstructured":"Perni, S., Jimenez, R. & Jagsi, R. Optimizing informed consent in cancer clinical trials. Semin. Radiat. Oncol. 33, 349\u2013357 (2023).","journal-title":"Semin. Radiat. Oncol."},{"key":"2631_CR311","doi-asserted-by":"crossref","unstructured":"Sarkar, C. et al. Artificial intelligence and machine learning technology driven modern drug discovery and development. Int. J. Mol. Sci. 24, 2026 (2023).","DOI":"10.3390\/ijms24032026"},{"key":"2631_CR312","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cts.13431","volume":"16","author":"M van der Lee","year":"2023","unstructured":"van der Lee, M. & Swen, J. J. Artificial intelligence in pharmacology research and practice. Clin. Transl. Sci. 16, 31\u201336 (2023).","journal-title":"Clin. Transl. Sci."},{"key":"2631_CR313","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/cpt.3542","volume":"117","author":"D Wilczok","year":"2025","unstructured":"Wilczok, D. & Zhavoronkov, A. Progress, pitfalls, and impact of AI-driven clinical trials. Clin. Pharmacol. Ther. 117, 887\u2013890 (2025).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2631_CR314","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2024.02.010","volume":"187","author":"BA Aguado","year":"2024","unstructured":"Aguado, B. A. et al. The future of sex and gender in research. Cell 187, 1354\u20131357 (2024).","journal-title":"Cell"},{"key":"2631_CR315","doi-asserted-by":"publisher","first-page":"n735","DOI":"10.1136\/bmj.n735","volume":"372","author":"S Bewley","year":"2021","unstructured":"Bewley, S., McCartney, M., Meads, C. & Rogers, A. Sex, gender, and medical data. BMJ 372, n735 (2021).","journal-title":"BMJ"},{"key":"2631_CR316","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/jamia\/ocab287","volume":"29","author":"MR Boland","year":"2022","unstructured":"Boland, M. R., Elhadad, N. & Pratt, W. Informatics for sex- and gender-related health: understanding the problems, developing new methods, and designing new solutions. J. Am. Med. Inform. Assoc. 29, 225\u2013229 (2022).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"2631_CR317","doi-asserted-by":"publisher","first-page":"e213909","DOI":"10.1001\/jamanetworkopen.2021.3909","volume":"4","author":"Y Park","year":"2021","unstructured":"Park, Y. et al. Comparison of methods to reduce bias from clinical prediction models of postpartum depression. JAMA Netw. Open 4, e213909 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2631_CR318","doi-asserted-by":"publisher","first-page":"100192","DOI":"10.1016\/j.xgen.2022.100192","volume":"2","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. Global biobank meta-analysis initiative: powering genetic discovery across human disease. Cell Genom. 2, 100192 (2022).","journal-title":"Cell Genom."},{"key":"2631_CR319","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00930-2","volume":"10","author":"X Jian","year":"2020","unstructured":"Jian, X. et al. Genome-wide association study of cognitive function in diverse Hispanics\/Latinos: results from the Hispanic Community Health Study\/Study of Latinos. Transl. Psychiatry 10, 245 (2020).","journal-title":"Transl. Psychiatry"},{"key":"2631_CR320","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s43018-022-00510-x","volume":"4","author":"S Migliozzi","year":"2023","unstructured":"Migliozzi, S. et al. Integrative multi-omics networks identify PKC\u03b4 and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nat. Cancer 4, 181\u2013202 (2023).","journal-title":"Nat. Cancer"},{"key":"2631_CR321","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41556-023-01316-4","volume":"26","author":"C Bravo Gonz\u00e1lez-Blas","year":"2024","unstructured":"Bravo Gonz\u00e1lez-Blas, C. et al. Single-cell spatial multi-omics and deep learning dissect enhancer-driven gene regulatory networks in liver zonation. Nat. Cell Biol. 26, 153\u2013167 (2024).","journal-title":"Nat. Cell Biol."},{"key":"2631_CR322","doi-asserted-by":"publisher","first-page":"116925","DOI":"10.1016\/j.ejmech.2024.116925","volume":"280","author":"I Fatima","year":"2024","unstructured":"Fatima, I. et al. Breakthroughs in AI and multi-omics for cancer drug discovery: a review. Eur. J. Med. Chem. 280, 116925 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"2631_CR323","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06368-8","volume":"23","author":"Z Wen","year":"2025","unstructured":"Wen, Z. et al. Genetic insights into idiopathic pulmonary fibrosis: a multi-omics approach to identify potential therapeutic targets. J. Transl. Med. 23, 337 (2025).","journal-title":"J. Transl. Med."},{"key":"2631_CR324","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106585","volume":"187","author":"R Gao","year":"2023","unstructured":"Gao, R. et al. Secreted MUP1 that reduced under ER stress attenuates ER stress induced insulin resistance through suppressing protein synthesis in hepatocytes. Pharmacol. Res. 187, 106585 (2023).","journal-title":"Pharmacol. Res."},{"key":"2631_CR325","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.21037\/jtd-24-1113","volume":"16","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Identification of serum biomarkers and therapeutic targets for aortic diseases in obesity through multi-omics analysis. J. Thorac. Dis. 16, 8435\u20138449 (2024).","journal-title":"J. Thorac. Dis."},{"key":"2631_CR326","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.csbj.2020.10.001","volume":"18","author":"YX Chen","year":"2020","unstructured":"Chen, Y. X. et al. An integrative multi-omics network-based approach identifies key regulators for breast cancer. Comput. Struct. Biotechnol. J. 18, 2826\u20132835 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2631_CR327","doi-asserted-by":"crossref","unstructured":"Kim, N. et al. CCR8 as a therapeutic novel target: omics-integrated comprehensive analysis for systematically prioritizing indications. Biomedicines 11, 2910 (2023).","DOI":"10.3390\/biomedicines11112910"},{"key":"2631_CR328","doi-asserted-by":"publisher","first-page":"982746","DOI":"10.3389\/fimmu.2022.982746","volume":"13","author":"W Vos","year":"2022","unstructured":"Vos, W. et al. The 2000HIV study: design, multi-omics methods and participant characteristics. Front. Immunol. 13, 982746 (2022).","journal-title":"Front. Immunol."},{"key":"2631_CR329","doi-asserted-by":"publisher","first-page":"167688","DOI":"10.1016\/j.bbadis.2025.167688","volume":"1871","author":"B Yang","year":"2025","unstructured":"Yang, B. et al. NetSDR: Drug repurposing for cancers based on subtype-specific network modularization and perturbation analysis. Biochim. Biophys. Acta Mol. Basis Dis. 1871, 167688 (2025).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"2631_CR330","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03139-9","volume":"14","author":"E Zillich","year":"2024","unstructured":"Zillich, E. et al. Multi-omics profiling of DNA methylation and gene expression alterations in human cocaine use disorder. Transl. Psychiatry 14, 428 (2024).","journal-title":"Transl. Psychiatry"},{"key":"2631_CR331","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/omi.2013.0100","volume":"18","author":"K Karaosmanoglu","year":"2014","unstructured":"Karaosmanoglu, K., Sayar, N. A., Kurnaz, I. A. & Akbulut, B. S. Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning. OMICS 18, 42\u201353 (2014).","journal-title":"OMICS"},{"key":"2631_CR332","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100632","volume":"22","author":"J Krumm","year":"2023","unstructured":"Krumm, J. et al. High-throughput screening and proteomic characterization of compounds targeting myeloid-derived suppressor cells. Mol. Cell Proteom. 22, 100632 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"2631_CR333","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1021\/acs.jnatprod.2c00146","volume":"85","author":"T Hell","year":"2022","unstructured":"Hell, T. et al. Combining activity profiling with advanced annotation to accelerate the discovery of natural products targeting oncogenic signaling in melanoma. J. Nat. Prod. 85, 1540\u20131554 (2022).","journal-title":"J. Nat. Prod."},{"key":"2631_CR334","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.aca.2019.04.038","volume":"1070","author":"L Ory","year":"2019","unstructured":"Ory, L. et al. Targeting bioactive compounds in natural extracts\u2014development of a comprehensive workflow combining chemical and biological data. Anal. Chim. Acta 1070, 29\u201342 (2019).","journal-title":"Anal. Chim. Acta"},{"key":"2631_CR335","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05654-4","volume":"25","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug-drug interaction prediction. BMC Bioinforma. 25, 39 (2024).","journal-title":"BMC Bioinforma."},{"key":"2631_CR336","doi-asserted-by":"publisher","first-page":"108768","DOI":"10.1016\/j.compbiomed.2024.108768","volume":"178","author":"Z Wang","year":"2024","unstructured":"Wang, Z. & Wei, Z. A framework for pre-training biomedical knowledge graphs with graph neural networks. Comput. Biol. Med. 178, 108768 (2024).","journal-title":"Comput. Biol. Med."},{"key":"2631_CR337","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04763-2","volume":"23","author":"C He","year":"2022","unstructured":"He, C. et al. Multi-type feature fusion based on graph neural network for drug-drug interaction prediction. BMC Bioinforma. 23, 224 (2022).","journal-title":"BMC Bioinforma."},{"key":"2631_CR338","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ymeth.2020.05.007","volume":"179","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning. Methods 179, 37\u201346 (2020).","journal-title":"Methods"},{"key":"2631_CR339","doi-asserted-by":"crossref","unstructured":"Ren, Z. H. et al. BioChemDDI: predicting drug-drug interactions by fusing biochemical and structural information through a self-attention mechanism. Biology 11, 758 (2022).","DOI":"10.3390\/biology11050758"},{"key":"2631_CR340","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s42004-023-00825-5","volume":"6","author":"X Zang","year":"2023","unstructured":"Zang, X., Zhao, X. & Tang, B. Hierarchical molecular graph self-supervised learning for property prediction. Commun. Chem. 6, 34 (2023).","journal-title":"Commun. Chem."},{"key":"2631_CR341","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. DEML: drug synergy and interaction prediction using ensemble-based multi-task learning. Molecules 28, 844 (2023).","DOI":"10.3390\/molecules28020844"},{"key":"2631_CR342","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00726-021-03108-2","volume":"54","author":"A Coaviche-Yoval","year":"2022","unstructured":"Coaviche-Yoval, A. et al. In silico and in vivo neuropharmacological evaluation of two \u03b3-amino acid isomers derived from 2,3-disubstituted benzofurans, as ligands of GluN1-GluN2A NMDA receptor. Amino Acids 54, 215\u2013228 (2022).","journal-title":"Amino Acids"},{"key":"2631_CR343","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1111\/bph.15076","volume":"177","author":"Y Tang","year":"2020","unstructured":"Tang, Y. et al. Structure-based discovery of CZL80, a caspase-1 inhibitor with therapeutic potential for febrile seizures and later enhanced epileptogenic susceptibility. Br. J. Pharmacol. 177, 3519\u20133534 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"2631_CR344","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.877706","volume":"13","author":"SJ Qiang","year":"2022","unstructured":"Qiang, S. J. et al. The discovery of novel PGK1 activators as apoptotic inhibiting and neuroprotective agents. Front. Pharmacol. 13, 877706 (2022).","journal-title":"Front. Pharmacol."},{"key":"2631_CR345","doi-asserted-by":"crossref","unstructured":"Pandey, P. et al. Structure-based identification of potent natural product chemotypes as cannabinoid receptor 1 inverse agonists. Molecules 23, 2630 (2018).","DOI":"10.3390\/molecules23102630"},{"key":"2631_CR346","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1111\/bph.14220","volume":"175","author":"LC Ozhathil","year":"2018","unstructured":"Ozhathil, L. C. et al. Identification of potent and selective small molecule inhibitors of the cation channel TRPM4. Br. J. Pharmacol. 175, 2504\u20132519 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"2631_CR347","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1021\/acschembio.2c00234","volume":"17","author":"S Kampen","year":"2022","unstructured":"Kampen, S. et al. Structure-based discovery of negative allosteric modulators of the metabotropic glutamate receptor 5. ACS Chem. Biol. 17, 2744\u20132752 (2022).","journal-title":"ACS Chem. Biol."},{"key":"2631_CR348","doi-asserted-by":"crossref","unstructured":"Zhou, J. et al. Machine-learning-enabled virtual screening for inhibitors of lysine-specific histone demethylase 1. Molecules 26, 7492 (2021).","DOI":"10.3390\/molecules26247492"},{"key":"2631_CR349","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1021\/acs.jcim.3c00543","volume":"63","author":"L Wei","year":"2023","unstructured":"Wei, L. et al. Hit identification driven by combining artificial intelligence and computational chemistry methods: a PI5P4K-\u03b2 case study. J. Chem. Inf. Model. 63, 5341\u20135355 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"2631_CR350","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1039\/C5SC04272K","volume":"7","author":"D Reker","year":"2016","unstructured":"Reker, D., Schneider, P. & Schneider, G. Multi-objective active machine learning rapidly improves structure-activity models and reveals new protein-protein interaction inhibitors. Chem. Sci. 7, 3919\u20133927 (2016).","journal-title":"Chem. Sci."},{"key":"2631_CR351","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/17460441.2021.1918096","volume":"16","author":"F Boniolo","year":"2021","unstructured":"Boniolo, F. et al. Artificial intelligence in early drug discovery enabling precision medicine. Expert Opin. Drug Discov. 16, 991\u20131007 (2021).","journal-title":"Expert Opin. Drug Discov."},{"key":"2631_CR352","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1016\/j.csbj.2023.07.032","volume":"21","author":"A Limeta","year":"2023","unstructured":"Limeta, A. et al. Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors. Comput. Struct. Biotechnol. J. 21, 3912\u20133919 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2631_CR353","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01102-1","volume":"14","author":"E Fountzilas","year":"2022","unstructured":"Fountzilas, E., Tsimberidou, A. M., Vo, H. H. & Kurzrock, R. Clinical trial design in the era of precision medicine. Genome Med. 14, 101 (2022).","journal-title":"Genome Med."},{"key":"2631_CR354","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drudis.2021.09.006","volume":"27","author":"P Moingeon","year":"2022","unstructured":"Moingeon, P., Kuenemann, M. & Guedj, M. Artificial intelligence-enhanced drug design and development: toward a computational precision medicine. Drug Discov. Today 27, 215\u2013222 (2022).","journal-title":"Drug Discov. Today"},{"key":"2631_CR355","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/bs.pmbts.2022.02.002","volume":"190","author":"Z Ahmed","year":"2022","unstructured":"Ahmed, Z. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis. Prog. Mol. Biol. Transl. Sci. 190, 101\u2013125 (2022).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"2631_CR356","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188572","volume":"1876","author":"L Kolla","year":"2021","unstructured":"Kolla, L. et al. The case for AI-driven cancer clinical trials\u2014the efficacy arm in silico. Biochim Biophys. Acta Rev. Cancer 1876, 188572 (2021).","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"key":"2631_CR357","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02910-6","volume":"19","author":"D Hartl","year":"2021","unstructured":"Hartl, D. et al. Translational precision medicine: an industry perspective. J. Transl. Med. 19, 245 (2021).","journal-title":"J. Transl. Med."},{"key":"2631_CR358","doi-asserted-by":"publisher","first-page":"175628482513219","DOI":"10.1177\/17562848251321915","volume":"18","author":"R Sedano","year":"2025","unstructured":"Sedano, R. et al. Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review. Ther. Adv. Gastroenterol. 18, 17562848251321915 (2025).","journal-title":"Ther. Adv. Gastroenterol."},{"key":"2631_CR359","doi-asserted-by":"publisher","first-page":"20230211","DOI":"10.1259\/bjr.20230211","volume":"96","author":"L Wei","year":"2023","unstructured":"Wei, L. et al. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration. Br. J. Radiol. 96, 20230211 (2023).","journal-title":"Br. J. Radiol."},{"key":"2631_CR360","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/cpt.3153","volume":"115","author":"N Terranova","year":"2024","unstructured":"Terranova, N. & Venkatakrishnan, K. Machine learning in modeling disease trajectory and treatment outcomes: an emerging enabler for model-informed precision medicine. Clin. Pharmacol. Ther. 115, 720\u2013726 (2024).","journal-title":"Clin. Pharmacol. Ther."},{"key":"2631_CR361","first-page":"1","volume":"1375","author":"J Lorkowski","year":"2022","unstructured":"Lorkowski, J., Kolaszy\u0144ska, O. & Pokorski, M. Artificial intelligence and precision medicine: a perspective. Adv. Exp. Med. Biol. 1375, 1\u201311 (2022).","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02631-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02631-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02631-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:02:12Z","timestamp":1780441332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02631-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":361,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2631"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02631-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}